<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        3-6063-25
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1981
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ENDOXAN. VIAL 500 MG
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CYCLOPHOSPHAMIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        powder for solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        29.45
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="BAXTER ONCOLOGY" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            BAXTER ONCOLOGY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 540]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ZIMMO TRADING ESTABLISHMENT
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Baxter Deutschland GmbH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        L01AA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td><p><strong>Throughout this leaflet, Endoxan Injection will be called <u>Cyclophosphamide</u>.</strong></p><p><strong>Important things to know about Cyclophosphamide</strong></p><p>Your doctor has prescribed Cyclophosphamide because you have cancer that can be treated.</p><p>Cyclophosphamide is a medicine that kills cancer cells but, as a result, also attacks normal cells. It can therefore have a number of side effects. Your doctor will not give you Cyclophosphamide unless he or she thinks that your cancer is more of a risk to you than any possible side effects. Your doctor will check you regularly and treat any side effects where possible.</p><p>Cyclophosphamide:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; will reduce your blood cell count, which may make you feel tired and be more likely to get infections.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; can affect your kidneys and bladder. You may be given another medicine called Mesna to help prevent any damage. If you notice blood in your urine, tell your doctor immediately.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; like most anti-cancer or chemotherapy medicines, you may lose your hair (anything from thinning to total loss), although it should start to grow back once your treatment has finished.&nbsp; It may also make you feel sick or be sick.&nbsp; Your doctor can give you advice or medicines to help.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Men or women should not have a child during treatment with Cyclophosphamide or for at least 6 months after treatment. You should use an effective contraceptive. Ask your doctor for advice.</p><p><strong>Now read the rest of this leaflet. </strong>It includes other important information on the use of Cyclophosphamide that might be especially important for you.</p><p>&nbsp;</p><p>Cyclophosphamide<strong> </strong>is a cytotoxic drug or anti-cancer drug. It works by killing cancer cells, this is sometimes called &lsquo;chemotherapy&rsquo;.</p><p>It is used to treat lots of different cancers. Cyclophosphamide<strong> </strong>is often used together with other anti-cancer drugs or radiotherapy.</p><p>&nbsp;</p><p>Occasionally, some doctors may prescribe Cyclophosphamide for other conditions not related to cancer, your doctor will tell you if this applies to you.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>You will not be given Cyclophosphamide if:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have ever had an allergic reaction to Cyclophosphamide. An allergic reaction can include shortness of breath, wheezing, rash, itching or swelling of the face and lips</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; your bone marrow is not working properly (especially if you have previously had chemotherapy or radiotherapy). &nbsp;You will have blood tests to check how well your bone marrow is working</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have a urinary tract infection, which can be recognised as pain when passing urine (cystitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you currently have any infections</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have ever had kidney or bladder problems as a result of previous chemotherapy or radiotherapy</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have a condition which decreases your ability to urinate (Urinary outflow obstruction).</p><p>&nbsp;</p><p><strong>Tell your doctor if:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are already having, or have recently had, radiotherapy or chemotherapy</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have diabetes</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have liver or kidney problems. Your doctor will check how well your liver and kidneys are working by doing a blood test</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have had your adrenal glands removed</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have heart problems or have had radiotherapy in the area of your heart</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have poor general health or are frail</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are elderly.</p><p>&nbsp;</p><p><strong>Take special care with Cyclophosphamide</strong></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide can have effects on your blood and immune system.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood cells are made in your bone marrow. Three different types of blood cell are made:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; red blood cells, which carry oxygen around your body</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; white blood cells, which fight infection, and</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; platelets, which help your blood to clot.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; After taking Cyclophosphamide,<strong> </strong>your blood count of the three types of cells will drop. This is an unavoidable side effect of Cyclophosphamide. Your blood count will reach its lowest level about 5 to 10 days after you start taking Cyclophosphamide and will stay low until a few days after you finish the course.<strong> </strong>Most people recover to a normal blood count within 21 to 28 days. If you have had a lot of chemotherapy in the past, it may take a little longer to return to normal.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You may be more likely to get infections when your blood count drops. Try to avoid close contact with people who have coughs, colds and other infections.&nbsp; Your doctor will treat you with appropriate medicine if they think you have, or are at risk, of an infection.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your doctor will check that the number of red blood cells, white blood cells and platelets is high enough before and during your treatment with Cyclophosphamide. They may need to reduce the amount you are given or delay your next dose.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide can affect wound healing.&nbsp; Keep any cuts clean and dry, and check they are healing normally.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It is important to keep your gums healthy, as mouth ulcers and infections can occur. Ask your doctor about this if you are unsure.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide can damage the lining of your bladder, causing bleeding into your urine and pain on urination. Your doctor knows this can happen and, if necessary, he or she will give you a medicine called Mesna which will protect your bladder.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mesna can either be given to you as a short injection, or mixed into the drip solution with your Cyclophosphamide, or as tablets.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; More information on Mesna can be found in the Patient Information Leaflet for Mesna Injection and Mesna tablets.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Most people having Cyclophosphamide with Mesna do not develop any problems with their bladder, but your doctor may want to test your urine for the presence of blood using a &lsquo;dipstick&rsquo; or microscope.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you notice that you have blood in the urine, you must tell your doctor straight away as they may need to stop giving you Cyclophosphamide.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cancer medicines and radiation therapy can increase the risk of you developing other cancers; this can be a number of years after your treatment has stopped.&nbsp; Cyclophosphamide has an increased risk of causing cancer in the area of your bladder.&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide can cause damage to your heart or affect the rhythm of it beating.&nbsp; This increases with higher doses of Cyclophosphamide, if you are being treated with radiation or other chemotherapy medicines or if you are elderly. &nbsp;Your doctor will monitor your heart closely during treatment.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide can cause inflammation or scarring in your lungs.&nbsp; This can occur more than six months after your treatment.&nbsp; If you start having difficulty breathing tell your doctor straight away.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide can have life threatening effects on your liver.&nbsp;</p><p>If you have sudden weight gain, liver pain and jaundice tell your doctor straight away.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Hair thinning or baldness can occur.&nbsp; Your hair should grow back normally though it may be different in texture or colour.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide can make you feel sick or be sick.&nbsp; This can last for about 24 hours after taking Cyclophosphamide. You may need to be given medicines to stop feeling or being sick. Ask your doctor about this.</p><p>&nbsp;</p><p><strong>Using other medicines and treatments</strong></p><p>Tell your doctor or nurse if you are taking or have recently taken any other medicines, including medicines you have bought yourself.&nbsp; In particular, tell them about the following medicines or treatments as they may not work well with Cyclophosphamide:</p><p>&nbsp;</p><p>The following medicines can reduce how effective Cyclophosphamide is:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; aprepitant (used to prevent being sick)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bupropion (an anti-depressant)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; busulfan, thiotepa (used to treat cancer)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ciprofloxacin, chloramphenicol (used to treat bacterial infections)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fluconazole, itraconazole (used to treat fungal infections)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prasugrel (used to thin the blood)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sulfonamides, such as sulfadiazine, sulfasalazine, sulfamethoxazole (used to treat bacterial infections).</p><p>&nbsp;</p><p>The following medicines can increase the toxicity of Cyclophosphamide:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allopurinol (used to treat gout)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; azathioprine (used to reduce the activity of the immune system)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chloral hydrate (used to treat insomnia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cimetidine (used to reduce stomach acid)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; disulfiram (used to treat alcoholism)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; glyceraldehyde (used to treat warts)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; protease inhibitors (used to treat viruses)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ondansetron (used to prevent being sick)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines that increase liver enzymes such as:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rifampicin (used to treat bacterial infections)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; carbamazepine, phenobarbital, phenytoin (used to treat epilepsy)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; St. John&rsquo;s wort (a herbal remedy for mild depression)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corticosteroids (used to treat inflammation)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines that can increase the toxic effects on your blood cells and immunity</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; ACE inhibitors (used to treat high blood pressure).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; natalizumab (used to treat multiple sclerosis)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; paclitaxel (used to treat cancer)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; thiazide diuretics such as hydrochlorothiazide or chlortalidone (used to treat high blood pressure or water retention)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; zidovudine&nbsp; (used to treat viruses)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Clozapine (used to treat symptoms of some psychiatric disorders)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines that can increase the toxic effects on your heart</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; anthracyclines such as bleomycin, doxorubicin, epirubicin, mitomycin (used to treat cancer)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; cytarabine, pentostatin, trastuzumab (used to treat cancer)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; radiation in the area of your heart</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines that can increase the toxic effects on your lungs</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; amiodarone (used to treat irregular heart beat)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; G-CSF, GM-CSF hormones (used to increase white blood cell numbers after chemotherapy)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines that can increase the toxic effects on your kidneys</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; amphotericin B (used to treat fungal infections)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Indomethacin (used to treat pain and inflammation).</p><p>&nbsp;</p><p>Other medicines that can affect or be affected by Cyclophosphamide include:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; etanercept (used to treat rheumatoid arthritis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; metronidazole (used to treat bacterial or protozoal infections)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tamoxifen (used to treat breast cancer)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bupropion (used to help stop smoking)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; coumarins such as warfarin (used to thin the blood)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cyclosporine (used to reduce the activity of the immune system)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; succinylcholine (used to relax muscles during medical procedures)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; digoxin, &beta;-acetyldigoxin (used to treat heart conditions)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; vaccines</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; verapamil (used to treat high blood pressure, angina or irregular heart beat).</p><p>&nbsp;</p><p><strong>Cyclophosphamide with food and drink</strong></p><p>Drinking alcohol can increase the nausea and vomiting caused by Cyclophosphamide.</p><p>&nbsp;</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p>Do not become pregnant while taking Cyclophosphamide.&nbsp; This is because it can cause miscarriage or damage your unborn baby. Tell your doctor if you are pregnant, think you might be pregnant or are trying to become pregnant.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Men or women should not try to have a child during or for at least 6 to 12 months after treatment. You should use an effective contraceptive. Ask your doctor for advice.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide can affect your ability to have children in the future.&nbsp; Talk to your doctor about freezing sperm samples or eggs before your treatment starts.</p><p>Do not breast-feed while being treated with Cyclophosphamide. Ask your doctor for advice.</p><p>&nbsp;</p><p><strong>Driving or using machines</strong></p><p>Some of the side effects of treatment with Cyclophosphamide might affect your ability to drive and use machines safely. Your doctor will decide if it is safe for you to do so.</p><p>&nbsp;</p><p><strong>What to do if you see a different doctor, or have to go to hospital</strong></p><p>If you see any other doctor or have to go to hospital for any reason, tell them what medicines you are taking. Do not take any other medicines unless your doctor knows you are taking Cyclophosphamide.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Cyclophosphamide will be given to you by a doctor or nurse.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It can be given as an injection or by mouth.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; When Cyclophosphamide is given as an injection, it will normally be added to a large bag of fluid and will be slowly injected (infused) directly into your vein. The vein can be in your arm, the back of your hand or a large vein under your collar bone. Depending on your dose, it will usually take between a few minutes to an hour to be given.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; When Cyclophosphamide is given by mouth, it will usually be made in to a solution with some flavourings (called an &lsquo;elixir&rsquo;) which will make it taste pleasant and easier to swallow.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cyclophosphamide is often given with other anti-cancer drugs or radiotherapy.</p><p><strong>The usual dose</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your doctor will decide how much of the medicine you need and when you should be given it.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The amount of Cyclophosphamide you will be given depends on:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; the type of illness you have</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; how big you are (a combination of your height and weight)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; your general health</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; whether you are being given other anti-cancer drugs or having radiotherapy.</p><p>&nbsp;</p><p>Cyclophosphamide is usually given as a series of courses of treatment.&nbsp; After each course there is a break (a period when no Cyclophosphamide is given) before the next course.</p><p>&nbsp;</p><p>Your doctor may need to change the amount of medicine you are given and monitor you more closely if you:</p><ul><li>have problems with your liver or kidneys</li><li>you are elderly.</li></ul><p>&nbsp;</p><p><strong>If you take too much Cyclophosphamide</strong></p><p>In the event of an overdose, or if a child swallows any of your tablets, talk to your doctor or local hospital emergency department immediately. Hospital admission for special treatment may be needed.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Cyclophosphamide can cause side effects, although not everybody gets them. Side effects can sometimes occur after ending the treatment. The following side effects may happen with this medicine.</p><p>&nbsp;</p><p><strong>Tell your doctor straight away, if you notice any of the following serious side effects:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allergic reactions, signs of this would be shortness of breath, wheezing, rash, itching or swelling of the face and lips</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; getting bruises without knocking yourself, or bleeding from your gums. This may be a sign that the platelet levels in your blood are getting too low</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a lowering of your white blood cell count, your doctor will check this during your treatment. It will not cause any signs, but you will be more likely to get infections. If you think you have an infection (a high temperature, feeling cold and shivery, or hot and sweaty, or any signs of infection such as a cough, or stinging on passing water) you may need antibiotics to fight infections because your blood count is lower than usual</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; very pale, lethargic and tired. This may be a sign of low red blood cells (anaemia). Usually, no treatment is required, your body will eventually replace the red blood cells. If you are very anaemic, you may need a blood transfusion</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood in your urine, pain while passing urine, or less urine being passed.</p><p>&nbsp;</p><p><strong>Other possible side effects may be:</strong></p><p>&nbsp;</p><p>Immune system and Infections</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; allergic reactions, signs of this would be shortness of breath, wheezing, rash, itching or swelling of the face and lips (hypersensitivity).&nbsp; Severe allergic reactions could lead to difficulty in breathing or shock, with a possible fatal outcome (anaphylactic shock, anaphylactic/anaphylactoid reaction)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; reduction in the effectiveness of your immune system (immunosuppression)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased risk and severity of bacterial, fungal, viral, protozoal or parasitic infections due to the effect of cyclophosphamide on your immune system</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reactivation of infections you have had before (latent infections)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe infection spreading through the blood which may lead to a dangerous drop in blood pressure with a possible fatal outcome (sepsis, shock).</p><p>&nbsp;</p><p>Cancers</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; cancer of your blood (leukaemia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; cancer of the bone marrow (myelodysplastic syndrome)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; cancer of the lymphatic system (Non-Hodgkin&rsquo;s lymphoma)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; secondary tumours in various parts of the body, often in the area of the bladder</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; changes to your metabolism caused by the breakdown of the dying cancer cells (Tumour lysis syndrome).</p><p>&nbsp;</p><p>Blood and Lymphatic System</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in the activity of your bone marrow (myelosuppression).&nbsp; This can cause a decrease in the number of cells in your blood:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; white cells - which fight infection (leucopenia, agranulocytosis, granulocytopenia, lymphopenia, neutropenia).&nbsp; This may be associated with fever (febrile neutropenia)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; platelets - which help your blood clot (thrombocytopenia)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; red cells - which carry oxygen around the body (anaemia).&nbsp; This may be associated with a decrease in their ability to carry oxygen (decreased haemoglobin)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; red cells, white cells and platelets at the same time (pancytopenia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; formation of small blood clots in your blood vessels disrupting the normal blood flow around your body (disseminated intravascular coagulation)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; haemolytic uremic syndrome - a condition causing abnormal break down of the red blood cells, decreased numbers of platelets in the blood and kidney failure.</p><p>&nbsp;</p><p>Endocrine System</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling of the brain due to too much water in your blood (water intoxication).&nbsp; Signs of this can be headache, changes in personality or behaviour, confusion, drowsiness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increase in the release of antidiuretic hormone from the pituitary gland.&nbsp; This affects the kidneys causing the low levels of sodium in your blood (hypernatremia) and water retention.</p><p>&nbsp;</p><p>Metabolism and Nutrition</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low blood levels of sodium which can cause tiredness and confusion, muscle twitching, fits and coma (hyponatremia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; accumulation of fluid in the body (water retention), which may been seen as fluid beneath the skin or swelling in you limbs</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; high blood sugar levels which can cause thirst, tiredness and irritability (hyperglycaemia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low blood sugar levels which can cause confusion and sweating (hypoglycaemia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; loss of appetite (anorexia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dehydration.</p><p>&nbsp;</p><p>Digestive system</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling sick and being sick (nausea, vomiting).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of your intestines or bowel which may resulting in bleeding (enteritis, cecitis, hemorrhagic enterocolitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; bleeding in your stomach or intestines (gastrointestinal haemorrhage)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tummy discomfort or severe tummy and back pain, this may be caused by inflammation of the pancreas (acute pancreatitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation which causes abdominal pain or diarrhoea (colitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; constipation or diarrhoea</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ulcers in the lining of your digestive system (mucosal ulceration)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the lining of your mouth including ulcers (stomatitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling of the glands in your neck (parotid gland inflammation).</p><p>&nbsp;</p><p>Psychiatric Disorders</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Confusion</p><p>&nbsp;</p><p>Nervous System</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; effects on the brain (encephalopathy), signs of this can be problems in thinking or concentrating, reduced alertness, changes in personality, tiredness, fits, muscle twitching, and shaking</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fits (convulsions)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dizziness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a syndrome called Reversible posterior leukoencephalopathy syndrome, which can cause swelling of the brain, headache, confusion, fits and loss of sight</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; effects on the spinal cord (Myelopathy), which can cause numbness, weakness and tingling in the hands, loss of motor skills</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a disorder of the nerves which can cause weakness, tingling or numbness (peripheral neuropathy).&nbsp; This could be in more than one set of nerves (polyneuropathy)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain from your nerves, which can also feel like an aching or burning sensation (neuralgia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tingling or numbness, often in the hands or feet (paresthesia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shaking (tremor)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in your sense of touch (dysesthesia) or loss of sensation (hypoesthesia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in your sense of taste (dysgeusia) or loss of taste (hypogeusia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in your sense of smell (parosmia).</p><p>&nbsp;</p><p>Eyes and Ears</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blurring, reduction or loss of sight</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the eye (conjunctivitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased tear formation (lacrimation).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; deafness or hearing impairment</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ringing in the ears (tinnitus).</p><p>&nbsp;</p><p>Heart and Circulation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart attack (myocardial infarction)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in your heart rhythm (arrhythmia) which may be noticeable (palpitations):</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; irregular heart beat (fibrillation)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; faster heart beat (tachycardia), which may be life threatening (ventricular tachycardia)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; slower heart beat (bradycardia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in your hearts ability to pump enough blood around your body which may be life threatening (cardiogenic shock, heart failure or cardiac arrest)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; disease of the heart muscle (cardiomyopathy)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the tissues in or around your heart (myocarditis, pericarditis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; build up of fluid in the sac around your heart (pericardial effusion).&nbsp; Increased pressure from this fluid can stop the heart filling properly (cardiac tamponade)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal ECG heart tracing (Electrocardiogram QT prolonged).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; blood clot in the lungs which causes chest pain and breathlessness (pulmonary embolism)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; blood clot, usually in a leg, which causes pain swelling or redness (venous thrombosis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the blood vessels (vasculitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; reduced blood supply to your hands and feet (peripheral ischemia ).&nbsp; This may cause pain, weakness, numbness, ulcers, changes in skin colour or temperature</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low or high blood pressure (hypotension, hypertension)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reddening of the skin (flushing) which may be accompanied by feeling hot or sweating (hot flushing).</p><p>&nbsp;</p><p>Lungs</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; life-threatening decrease of your lungs ability to transfer oxygen in to your blood (respiratory failure)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood clot in the lungs which causes chest pain and breathlessness (pulmonary veno-occlusive disease)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; scarring of the lungs which causes shortness of breath (pulmonary fibrosis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; conditions causing inflammation of the lungs which can cause breathlessness, cough and raised temperature or scarring of the lungs (pneumonitis, acute respiratory distress syndrome, obliterative bronchiolitis, organizing pneumonia, alveolitis allergic)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fluid in or around the lungs (pulmonary oedema, pleural effusion)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased blood pressure in the lungs which can cause shortness of breath, fatigue, cough, angina, fainting, peripheral oedema (pulmonary hypertension)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty in breathing or wheezing (bronchospasm)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shortness of breath (dyspnea)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease levels of oxygen in your body (hypoxia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cough</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blocked or runny nose</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain at the back of your throat.</p><p>&nbsp;</p><p>Liver</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased liver size (hepatomegaly)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; yellowing of the skin or whites of the eyes (jaundice)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blockage of the small veins in your liver (veno-occlusive liver disease) which can cause weight gain, increased liver size, pain and jaundice</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; conditions causing inflammation of the liver which can cause jaundice, weight loss and malaise (hepatitis),</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; disruption of the formation of bile by the liver which can cause itchiness, jaundice, pale coloured stools, dark urine (cholestasis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a build up of toxins in the body due to liver failure (hepatotoxicity).&nbsp; This may affect the brain causing confusion, reduced consciousness or coma (hepatic encephalopathy)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a build up of fluid in the abdomen causing swelling of the tummy and shortness of breath (ascites)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increased levels of certain proteins produced by your liver called enzymes.&nbsp; Your doctor will do blood tests to test for these.</p><p>&nbsp;</p><p>Skin and Subcutaneous Tissue</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; life threatening conditions which cause rash, ulcers, sore throat, fever, conjunctivitis, separation of skin layers (toxic epidermal necrolysis, Stevens-Johnson syndrome)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling, numbness, red lumps and peeling of skin on the hands and feet (Palmar-plantar erythrodysesthesia syndrome)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dark red raised itchy rash (urticaria)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of this skin which may cause rash, blisters, itching, sores, oozing and scarring (dermatitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; redness and blistering of the skin appearing months or years after treatment (Radiation recall dermatitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itchy, red rash which can develop in to sores (erythema multiforme)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in colour of your fingernails and skin.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; separation of the nail bed which can cause nails to fall off</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dehydration</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; excessive sweating (hyperhidrosis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling of the face</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hair loss (alopecia).</p><p>&nbsp;</p><p>Musculoskeletal and Connective Tissue</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal muscle breakdown which can lead to kidney problems (rhabdomyolysis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; serious illness which causes thickening of the skin and the connective tissue in your internal organs (scleroderma)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; muscle spasms</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; muscle pain (myalgia) or joint pain (arthralgia).</p><p>&nbsp;</p><p>Renal and Urinary</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; life threatening decrease in the abilities of your kidney to adequately remove toxins and waste products from the blood (kidney failure)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes to the tissues within your kidneys which prevent them from working correctly (renal tubular necrosis, renal tubular disorder)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; damage to the kidneys by toxins in the blood (toxic nephropathy)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain and difficultly passing urine (cystitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood in the urine (haematuria)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; glucose in the urine (nephrogenic diabetes insipidus)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the bladder lining which causes pain, bleeding, blood in the urine, reduced urine flow (haemorrhagic cystitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the urethra which causes pain and bleeding. (haemorrhagic ureteritis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; death of the cells and tissues (necrosis), ulceration or scaring (fibrosis) of the bladder</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in the size of the bladder (bladder contracture)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes to the cells in the lining of your bladder</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increase in the levels of creatinine or urea nitrogen in your blood.&nbsp; Your doctor will do blood tests to test for these.</p><p>&nbsp;</p><p>Pregnancy and Fertility</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; premature labour.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; infertility.&nbsp; Sperm production in men and egg production in women may be reduced or stop.&nbsp; In some cases this can be permanent</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; absence of menstrual periods (amenorrhea) or reduced frequency (oligomenorrhea)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in testicle size (testicular atrophy)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in the hormone oestrogen in the blood</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increase in the hormone gonadotrophin in the blood.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; use in young patients may result in some impairments of future fertility.</p><p>&nbsp;</p><p>Congenital, Familial and Genetic Disorders</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reduction in growth, deformity or death of a foetus while in the womb</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; toxic effects on the foetus such as myelosuppression and gastroenteritis.</p><p>&nbsp;</p><p>General Disorders and Administrative Site Conditions</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; life threatening failure of multiple organs</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; general physical deterioration</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; flu-like symptoms such as headache, fever, chills, joint and muscle pain, weakness, tiredness</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chest pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Injection/infusion site reactions such as swelling, redness, pain, inflammation, tissue damage, tissue death, clot formation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation of the linings of your body cavities (mucosal inflammation).</p><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><ul><li><strong>Saudi Arabia:</strong></li></ul><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>&sect;&nbsp; Fax: +966-11-205-7662</p><p>&sect;&nbsp; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>&sect;&nbsp; Toll free phone: 8002490000</p><p>&sect;&nbsp; E-mail: npc.drug@sfda.gov.sa&nbsp;</p><p>&sect;&nbsp; Website: www.sfda.gov.sa/npc&nbsp;</p><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><ul><li><strong>Other GCC States:</strong></li></ul><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Because Cyclophosphamide is usually given in hospital it will be stored safely and correctly by the hospital staff. If you do need the storage conditions they are given below:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep this medicine out of the sight and reach of children.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use Cyclophosphamide after the expiry date which is stated on the label after EXP. The expiry date refers to the last day of that month.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not store above 25&ordm;C. Store in the original container.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What</strong><strong> Cyclophosphamide contains</strong></p><p>The active substance is Cyclophosphamide and each vial contains:</p><p>200 mg, 500&nbsp;mg or 1000 mg.</p><p>&nbsp;</p><p>There are no other ingredients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Cyclophosphamide looks like and contents of the pack
Cyclophosphamide is a dry, white powder supplied in clear glass vials. Each carton contains one vial.

Nature and contents of container
Vials are packed with or without a protective plastic overwrap. Protective plastic overwrap does not come into contact with the medicinal product and provides additional transport protection, which increases the safety for the medical and pharmaceutical personnel.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Baxter Oncology GmbH</p><p>Kantstra&szlig;e 2</p><p>33790&nbsp;Halle/Westfalen</p><p>Germany</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                April 2016
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td><p dir="RTL"><strong>في هذه النشرة، سيتم الإشارة إلى حقن إندوكسان باسم <u>سيكلوفوسفاميد</u>.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أمور مهمة ينبغي معرفتها عن دواء سيكلوفوسفاميد</strong></p><p dir="RTL">قام الطبيب بوصف دواء سيكلوفوسفاميد لك لأنك مصاب بسرطان يمكن علاجه.</p><p dir="RTL"><strong>سيكلوفوسفاميد </strong>هو دواء يقتل الخلايا السرطانية ولكن، نتيجة لذلك، فهو يهاجم الخلايا السليمة أيضًا. ومن ثم، فقد يسبب عدة آثار جانبية. لن يعطيك الطبيب دواء سيكلوفوسفاميد إلا إذا كان يعتقد أن السرطان الذي تعاني منه أشد خطرًا على حياتك من أي آثار جانبية محتملة. سيقوم الطبيب بفحصك بانتظام وعلاج أي آثار جانبية إن أمكن.</p><p dir="RTL"><strong>سيكلوفوسفاميد:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سوف يقلل من عدد خلايا الدم، مما قد يجعلك تشعر بالتعب وتزداد احتمالية تعرضك للإصابة بعدوى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يؤثر على الكلى والمثانة. قد يتم إعطاؤك دواء آخر يسمى ميسنا للمساعدة على منع حدوث أي ضرر. أخبر الطبيب على الفور إذا لاحظت وجود دم في البول.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مثل معظم الأدوية المضادة للسرطان أو العلاج الكيميائي، فقد يسقط شعرك (بداية من أن يخف قليلاً إلى الفقدان الكلي) مع استخدامه، ولكن من المفترض أن يبدأ في النمو من جديد بمجرد الانتهاء من العلاج.&nbsp; وقد يجعلك أيضًا تشعر بإعياء أو تصاب بالإعياء.&nbsp; يمكن للطبيب تقديم المشورة لك أو إعطاؤك أدوية للمساعدة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ينبغي على الرجال أو السيدات عدم محاولة الإنجاب أثناء العلاج بدواء سيكلوفوسفاميد أو لمدة 6 أشهر على الأقل بعد الانتهاء من العلاج. ينبغي استخدام وسيلة فعالة لمنع الحمل. يرجى استشارة الطبيب الخاص بك.</p><p dir="RTL">والآن، اقرأ باقي النشرة. فهي تشمل معلومات مهمة أخرى عن استخدام سيكلوفوسفاميد قد تهمك بشكل خاص.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>سيكلوفوسفاميد </strong>هو دواء سام للخلايا أو مضاد للسرطان. وهو يعمل عن طريق قتل الخلايا السرطانية، ويسمى أحيانًا &quot;بالعلاج الكيميائي&quot;.</p><p dir="RTL">يستخدم هذا الدواء لعلاج كثير من أنواع السرطان المختلفة. <strong>عادةً ما </strong>يستخدم سيكلوفوسفاميد مع أدوية مضادة للسرطان أخرى أو مع علاج إشعاعي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">في بعض الأحيان، قد يصف بعض الأطباء دواء سيكلوفوسفاميد لحالات أخرى غير مرتبطة بالسرطان، سوف يخبرك الطبيب إذا كان هذا ينطبق عليك.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لن يتم إعطاؤك سيكلوفوسفاميد:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا عانيت من حساسية لدواء سيكلوفوسفاميد من قبل. تتضمن أعراض الإصابة بحساسية ضيق التنفس أو أزيز أو طفح جلدي أو حكة أو تورم الوجه والشفتين</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان النخاع العظمي لديك لا يؤدي وظيفته بشكل صحيح (لاسيما إذا تلقيت علاجًا كيميائيًا أو إشعاعيًا سابقًا).&nbsp; سيتم إجراء اختبارات دم لك للتحقق من مدى قيام نخاع العظم بوظيفته</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من عدوى المسالك البولية، والتي يمكن معرفتها من الشعور بألم عند التبول (التهاب المثانة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك حاليًا أي عدوى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا عانيت من قبل من مشكلات في الكلى أو المثانة ناتجة عن علاج كيميائي أو إشعاعي سابق</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حالة تقلل من قدرتك على التبول (انسداد المسالك البولية)</p><p dir="RTL">&nbsp;</p><p dir="RTL">أخبر طبيبك إذا:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تخضع بالفعل أو خضعت مؤخرًا لعلاج إشعاعي أو كيميائي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت مصاب بداء السكري</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كانت لديك مشكلات في الكبد أو الكلى. سيقوم الطبيب بفحص وظائف الكبد والكلى عن طريق إجراء اختبار دم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خضعت لاستئصال الغدد الكظرية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كانت لديك مشكلات في القلب أو تلقيت علاجًا إشعاعيًا في منطقة القلب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من ضعف عام في الصحة أو الجسم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت من كبار السن</p><p dir="RTL">&nbsp;</p><p dir="RTL">توخي الحرص عند استخدام سيكلوفوسفاميد</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>يمكن أن يكون لدواء سيكلوفوسفاميد تأثير على الدم أو جهاز المناعة.</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تُصنع خلايا الدم في النخاع العظمي، حيث يتم تكوين ثلاثة أنواع مختلفة من خلايا الدم:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خلايا الدم الحمراء، والتي تنقل الأكسجين إلى أجزاء الجسم</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خلايا الدم البيضاء، التي تحارب العدوى و</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصفائح الدموية، والتي تساعد في عملية تجلط الدم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعد تناول سيكلوفوسفاميد،<strong> </strong>سوف ينخفض العد الدموي للأنواع الثلاثة من خلايا الدم. وهذا أثر جانبي لا يمكن تجنبه لدواء سيكلوفوسفاميد. سوف يصل العد الدموي لديك إلى أدنى مستوى له بعد مرور 5 إلى 10 أيام من البدء في تناول سيكلوفوسفاميد وسيظل منخفضًا لبضعة أيام بعد انتهاء مدة العلاج المحددة.<strong> </strong>يعود مستوى العد الدموي الطبيعي لدى معظم الأشخاص في غضون 21 إلى 28 يوم. إذا خضعت للكثير من العلاج الكيميائي في الماضي، فقد يستغرق الأمر مدة أطول قليلاً ليعود العد الدموي إلى طبيعته.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد تزداد احتمالية الإصابة بالعدوى عندما ينخفض العد الدموي لديك. حاول أن تتجنب الاتصال المباشر بالأشخاص المصابين بالسعال وبنزلات البرد وبالعدوى الأخرى.&nbsp; سوف يقوم الطبيب بعلاجك بالدواء المناسب، إذا رأي أنك مصاب أو أنك عرضة للإصابة بعدوى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سوف يتحقق الطبيب مما إذا كان عدد خلايا الدم الحمراء والبيضاء والصفائح الدموية مرتفعًا بشكلٍ كافٍ قبل وأثناء علاجك بدواء سيكلوفوسفاميد. وقد يحتاج إلى تقليل جرعة الدواء التي تتناولها أو تأخير جرعتك التالية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن أن يؤثر سيكلوفوسفاميد على التئام الجروح.&nbsp; حافظ على نظافة الجروح وجفافها، وتحقق مما إذا كانت تلتئم بشكل طبيعي أم لا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; من المهم أن تحافظ على صحة اللثة حيث قد تحدث تقرحات وعدوى في الفم. اسأل الطبيب عن هذا إذا لم تكن متأكدًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن أن يؤدي سيكلوفوسفاميد إلى تضرر بطانة المثانة، مما يسبب نزيف في البول وألم عند التبول. يعلم طبيبك بإمكانية حدوث هذا، وإذا لزم الأمر سيعطيك دواءً يسمى ميسنا والذي سيحمي المثانة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن إعطاء ميسنا إما على شكل حقن صغيرة أو عن طريق مزجها في محلول التنقيط مع سيكلوفوسفاميد أو على شكل أقراص.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن العثور على المزيد من المعلومات عن دواء ميسنا في نشرة معلومات المريض لحقن وأقراص ميسنا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يعاني معظم الأشخاص الذين يتناولون دواء سيكلوفوسفاميد مع دواء ميسنا من أي مشكلات في المثانة، ولكن قد يود الطبيب اختبار البول للتأكد من عدم وجود دم باستخدام &quot;غميسة&quot; أو مجهر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا لاحظت وجود دم في البول، يجب أن تخبر الطبيب مباشرةً حيث قد يحتاج إلى وقف إعطائك دواء سيكلوفوسفاميد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>يمكن أن تسبب أدوية السرطان والعلاج الإشعاعي احتمالية الإصابة بأنواع أخرى من السرطان؛ قد يحدث هذا بعد مرور عدة سنوات من إيقاف العلاج.&nbsp; يقترن سيكلوفوسفاميد باحتمالية كبيرة في التسبب في الإصابة بسرطان في منطقة من المثانة.&nbsp; </strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن أن يلحق سيكلوفوسفاميد ضررًا بالقلب أو يؤثر على نظم ضرباته.&nbsp; ويزداد هذا مع الجرعات العالية من سيكلوفوسفاميد، أو إذا كنت تتلقى علاجًا بالإشعاع أو أدوية علاج كيميائي أخرى أو إذا كنت من كبار السن.&nbsp; سوف يتابع الطبيب حالة قلبك عن كثب أثناء العلاج.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; يمكن أن يتسبب سيكلوفوسفاميد في التهاب في الرئتين أو تندبها.&nbsp; يمكن أن يحدث هذا بعد مرور أكثر من ستة أشهر من العلاج.&nbsp; إذا بدأت تواجه صعوبة في التنفس أخبر طبيبك على الفور.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; <strong>يمكن أن يكون لدواء سيكلوفوسفاميد آثار على الكبد مهددة للحياة.&nbsp; </strong></p><p dir="RTL">إذا زاد وزنك بشكل مفاجئ أو شعرت بألم في الكبد أو أصبت بيرقان، أخبر الطبيب على الفور.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; يمكن أن يخف الشعر أو يحدث صلع.&nbsp; من المفترض أن ينمو شعرك مرة أخرى بصورة طبيعية ولكنه قد يصبح مختلفًا في الملمس أو اللون.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; قد يجعلك سيكلوفوسفاميد تشعر بالإعياء أو تصاب بالإعياء.&nbsp; يمكن أن يستمر هذا لمدة 24 ساعة بعد تناول سيكلوفوسفاميد. قد تحتاج إلى أن يتم وصف أدوية لإيقاف الشعور بالإعياء أو التخلص من حالة الإعياء التي تصيبك. يرجى استشارة الطبيب بخصوص هذا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">استخدام أدوية وعلاجات أخرى</p><p dir="RTL">أخبر الطبيب أو الممرضة إذا كنت تتناول أو تناولت مؤخرًا أي أدوية أخرى، بما في ذلك الأدوية التي اشتريتها بنفسك.&nbsp; وينبغي أن تخبرهم خاصةً عن الأدوية أو العلاجات التالية، حيث قد تتعارض فعاليتها مع دواء سيكلوفوسفاميد:</p><p dir="RTL">&nbsp;</p><p dir="RTL">الأدوية التالية قد تقلل من فعالية دواء سيكلوفوسفاميد:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>أبريبيتانت (يستخدم لمنع الشعور بالإعياء)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>بوبروبيون (دواء مضاد للاكتئاب)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>بوسلفان وثيوتيبا (يستخدمان لعلاج السرطان)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>سيبروفلوكساسين وكلورامفينيكول (يستخدمان لعلاج العدوى البكتيرية)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>فلوكونازول وإيتراكونازول (يستخدمان لعلاج العدوى الفطرية)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>براسوجريل (يستخدم لتخفيف الدم)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>سلفوناميدات، مثل سولفاديازين وسلفاسالازين وسلفاميثوكسازول (تستخدم لعلاج العدوى البكتيرية)</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن أن تزيد الأدوية التالية من سمية دواء سيكلوفوسفاميد:</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>ألوبيورينول (يستخدم لعلاج النقرس)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>آزاثيوبرين (يستخدم لتقليل نشاط جهاز المناعة)</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>هيدرات الكلورال (يستخدم لعلاج الأرق)</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>سيميتيدين (يستخدم لتقليل أحماض المعدة)</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>ديسلفيرام (يستخدم لعلاج إدمان الكحوليات)</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>جليسرألديهيد (يستخدم لعلاج الثآليل)</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>مثبطات البروتياز (تستخدم لعلاج الفيروسات)</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>أوندانسيترون (يستخدم لمنع الشعور بالإعياء)</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الأدوية التي تزيد من إنزيمات الكبد مثل:</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>ريفامبيسين (يستخدم لعلاج العدوى البكتيرية)</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>كاربامازيبين وفينوباربيتال وفينيتوين (تستخدم لعلاج الصرع)</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>عشبة سانت جون (علاج عشبي للاكتئاب الخفيف)</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>كورتيكوستيرويد (يستخدم لعلاج الالتهاب)</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>أدوية قد تزيد من الآثار السامة على خلايا الدم والمناعة</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>مثبطات الإنزيم المحول للأنجيوتنسين (تستخدم لعلاج ضغط الدم المرتفع)</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>ناتاليزوماب (يستخدم لعلاج التصلب المتعدد)</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>باكليتاكسيل (يستخدم لعلاج السرطان)</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>مدرات البول المحتوية على ثيازيد مثل هيدروكلورثيازيد أو كلورثاليدون (تستخدم لعلاج ضغط الدم المرتفع أو احتباس الماء)</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>زيدوفيدين (يستخدم لعلاج الفيروسات)</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>كلوزابين (يستخدم لعلاج أعراض بعض الاضطرابات النفسية)</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>أدوية قد تزيد من الآثار السامة على القلب</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>أنثراسيكلينات مثل بليوميسين ودوكسوروبيسين وإيبيروبوسين وميتوميسِين (تستخدم لعلاج السرطان)</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>سيتارابين وبنتوستاتين وترازتوزوماب (تستخدم لعلاج السرطان)</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الإشعاع في منطقة في القلب</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>أدوية قد تزيد من الآثار السامة على الرئتين</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>أميودارون (يستخدم لعلاج نبضات القلب غير المنتظمة)</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>العامل المنبه لمستعمرات الخلايا المحببة وهرمونات العامل المنبه لمستعمرات الخلايا المحببة الأكولة (يستخدمان لزيادة أعداد خلايا الدم البيضاء بعد العلاج الكيميائي)</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>أدوية قد تزيد من الآثار السامة على الكلى</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>أمفوتيريسين ب (يستخدم لعلاج العدوى الفطرية)</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>إندوميتاسين (يستخدم لعلاج الألم والالتهاب).</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">تشمل الأدوية الأخرى التي قد تؤثر أو تتأثر بدواء سيكلوفوسفاميد:</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>إيتانيرسيبت (يستخدم لعلاج التهاب المفاصل الروماتويدي)</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>مترونيدازول (يستخدم لعلاج العدوى البكتيرية أو عدوى الكائنات الأولية)</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>تاموكسيفين (يستخدم لعلاج سرطان الثدي)</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>&rlm;</strong>‫<strong>بوبروبيون (يستخدم للمساعدة على التوقف عن التدخين)</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>كومارينات مثل وارفارين (يستخدم لتخفيف الدم)</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>سيكلوسبورين (يستخدم لتقليل نشاط جهاز المناعة)</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>سوكسميثونيوم (يستخدم لإرخاء العضلات أثناء الإجراءات الطبية)</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>ديجوكسين وبيتا أسيتلدايجوكسين (يستخدمان لعلاج حالات القلب)</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>اللقاحات</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>فيراباميل (يستخدم لعلاج ضغط الدم المرتفع والذبحة ونبضات القلب غير المنتظمة)</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">استخدام سيكلوفوسفاميد مع الطعام والشراب</p><p dir="RTL">يمكن أن يزيد شرب الكحول من الغثيان والقيء الذي يسببه سيكلوفوسفاميد.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الحمل والرضاعة الطبيعية والخصوبة</p><p dir="RTL">لا يجب الحمل وأنت تستخدمين سيكلوفوسفاميد.&nbsp; لأنه قد يتسبب في حدوث إجهاض أو قد يضر بالجنين. أخبري الطبيب إذا كنت حاملاً أو تفكرين في الحمل أو تحاولين الحمل.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ينبغي على الرجال أو السيدات عدم محاولة الإنجاب أثناء العلاج أو لمدة تتراوح بين 6 إلى 12 أشهر على الأقل بعد الانتهاء من العلاج. ينبغي استخدام وسيلة فعالة لمنع الحمل. يرجى استشارة الطبيب الخاص بك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن أن يؤثر سيكلوفوسفاميد على قدرتك على الإنجاب في المستقبل.&nbsp; يرجى التحدث إلى الطبيب عن تجميد عينات من الحيوانات المنوية أو البويضات قبل البدء في العلاج.</p><p dir="RTL">لا ترضعين رضاعة طبيعية أثناء العلاج بسيكلوفوسفاميد. يرجى استشارة الطبيب الخاص بك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">القيادة واستخدام الآلات</p><p dir="RTL">قد تؤثر بعض الآثار الجانبية للعلاج بدواء سيكلوفوسفاميد على قدرتك على القيادة واستخدام الآلات بشكل آمن. سيقرر طبيبك مدى أمان قيامك بهذا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ما عليك فعله إذا بدأت في استشارة طبيب آخر أو اضطررت للذهاب إلى المستشفى</p><p dir="RTL">إذا بدأت في استشارة طبيب آخر أو ذهبت إلى المستشفى لأي سبب، أخبرهم بالأدوية التي تستخدمها. لا تأخذ أي أدوية أخرى إلا بعد إخبار الطبيب بأنك تأخذ سيكلوفوسفاميد.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">سيتم إعطاؤك سيكلوفوسفاميد بواسطة الطبيب أو الممرضة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن إعطاؤه على شكل حقنة أو عن طريق الفم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عندما يتم إعطاء سيكلوفوسفاميد على شكل حقنة، سيتم إضافته إلى كيس كبير من السائل وسيتم حقنة ببطء (تسريبه) مباشرةً في الوريد. يمكن أن يكون الوريد في ذراعك أو ظهر اليد أو في وريد كبير أسفل عظمة الترقوة. بناءً على جرعتك، عادةً ما يستغرق إعطاؤها ما بين بضعة دقائق إلى ساعة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عندما يتم إعطاء سيكلوفوسفاميد عن طريق الفم، عادةً ما يتم إضافته إلى محلول يحتوي على بعض المنكهات (تسمى &quot;إكسير&quot;) والتي تجعل مذاقه مقبولاً ويصبح تناوله أسهل.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عادةً ما يستخدم سيكلوفوسفاميد مع أدوية مضادة للسرطان أخرى أو مع علاج إشعاعي.</p><p dir="RTL">الجرعة المعتادة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيقرر الطبيب الجرعة التي تحتاجها من الدواء ومتى يجب أخذها.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تتوقف الجرعة التي سيتم إعطاؤها لك من سيكلوفوسفاميد على:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوع المرض الذي تعاني منه</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حجمك (طولك مع وزنك)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صحتك العامة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا ما كنت تتناول أدوية أخرى مضادة للسرطان أو تتلقى علاجًا إشعاعيًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">عادةً ما يتم إعطاء دواء سيكلوفوسفاميد في شكل سلسلة من الدورات العلاجية.&nbsp; بعد كل دورة علاجية يكون هناك فترة راحة (فترة لا يتم فيها إعطاء سيكلوفوسفاميد) قبل الدورة التالية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يحتاج الطبيب إلى تغيير جرعة الدواء التي تأخذها ووضعك تحت الملاحظة الدقيقة إذا:</p><ul><li dir="RTL">كانت لديك مشكلات في الكبد أو الكلى</li><li dir="RTL">كنت من كبار السن</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا تناولت جرعة زائدة من دواء سيكلوفوسفاميد</strong></p><p dir="RTL">في حالة تناول جرعة مفرطة أو إذا ابتلع طفل أي من أقراصك، تحدث إلى الطبيب أو قسم الطوارئ في المستشفى المحلي على الفور. قد يتطلب الأمر الحجز في المستشفى لتلقي علاج خاص.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">قد يتسبب دواء سيكلوفوسفاميد في حدوث آثار جانبية، كغيره من الأدوية، ولكن ليس بالضرورة أن يصاب جميع الأشخاص بهذه الآثار الجانبية. في بعض الأحيان، قد تحدث آثار جانبية بعد انتهاء العلاج. قد تحدث الآثار الجانبية التالية مع هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أخبر الطبيب على الفور إذا لاحظت أي من الآثار الجانبية الخطيرة التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حساسية، وأعراضها: ضيق التنفس أو أزيز أو طفح جلدي أو حكة أو تورم الوجه والشفتين</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ظهور كدمات دون التعرض لخبطات أو نزيف من اللثة. قد يكون هذا علامة على انخفاض حاد في مستويات الصفائح الدموية في الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد خلايا الدم البيضاء، سيقوم الطبيب بفحص ذلك أثناء العلاج. لن يسبب ذلك ظهور أي علامات، ولكن ستزداد لديك احتمالية الإصابة بالعدوى. إذا كنت تعتقد أنك مصاب بعدوى (درجة حرارة مرتفعة أو شعور بالبرد والرعشة أو حرارة وتعرق أو أي علامات على الإصابة بالعدوى مثل السعال أو حرقان عند التبول) قد تحتاج إلى أخذ مضادات حيوية لمكافحة العدوى لأن العد الدموي لديك يكون أقل من الطبيعي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شحوب حاد أو كسل أو تعب. قد يكون هذا علامة على انخفاض خلايا الدم الحمراء (فقر دم). عادةً لا يتطلب الأمر أي علاج، حيث سيعوض جسمك خلايا الدم الحمراء في النهاية. إذا كنت مصابًا بفقر دم حاد، قد تحتاج إلى نقل دم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وجود دم في البول أو ألم أثناء التبول أو نزول مقدار صغير من البول.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد تتضمن الآثار الجانبية المحتملة الأخرى:</p><p dir="RTL">&nbsp;</p><p dir="RTL">الجهاز المناعي والعدوى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; حساسية، وأعراضها: ضيق التنفس أو أزيز أو طفح جلدي أو حكة أو تورم الوجه والشفتين (فرط الحساسية).&nbsp; يمكن أن تؤدي تفاعلات الحساسية الحادة إلى صعوبة في التنفس أو صدمة مع حدوث نتائج خطيرة محتملة (<strong>صدمة تأقية أو تفاعل تأقاني)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض كفاءة جهاز المناعة (تثبيط المناعة)</p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong>زيادة احتمالية وشدة الإصابة بعدوى بكتيرية أو فطرية أو فيروسية أو كائنات أولية أو طفيلية نتيجة لتأثير سيكلوفوسفاميد على جهاز المناعة</strong></p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong><em>إعادة تنشيط العدوى التي أُصبت بها من قبل (العدوى الكامنة)</em></strong></p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong>عدوى حادة تنتشر في الدم والتي قد تؤدي إلى انخفاض حاد في ضغط الدم مع حدوث نتائج خطيرة محتملة (إنتان الدم<strong><em>، صدمة).</em></strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">أنواع السرطان</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; سرطان في الدم (اللوكيميا)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; <strong>سرطان في نخاع العظام (متلازمة خلل التنسج النخاعي)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; <strong>سرطان الجهاز اللمفاوي (لمفومة لاهودجكينية)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; أورام ثانوية في أجزاء مختلفة من الجسم، غالبًا ما تكون في منطقة المثانة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في عملية التمثيل الغذائي بسبب انحلال الخلايا السرطانية الميتة (<strong>متلازمة انحلال الورم).</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الدم والجهاز اللمفاوي</strong></p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong><em>انخفاض في وظيفة النخاع العظمي (</em></strong><strong>تثبيط النخاع العظمي).&nbsp; يمكن أن يتسبب ذلك في انخفاض عدد الخلايا في الدم:</strong></p><p dir="RTL"><strong><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong><em>الخلايا البيضاء - والتي تحارب العدوى (</em></strong><strong>قلة الكريات البيض، ندرة المحببات، قلة المحببات، قلة اللمفاويات، قلة العَدِلات).&nbsp; قد يكون هذا مصحوبًا بحمى (حمى قلة العَدِلات)</strong></p><p dir="RTL"><strong><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong><em>الصفائح الدموية - والتي تساعد في عملية تجلط الدم</em></strong><strong> (قلة الصفيحات)</strong></p><p dir="RTL"><strong><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong><em>الخلايا الحمراء - والتي تنقل الأكسجين إلى أجزاء الجسم (فقر الدم).&nbsp; </em></strong><strong>قد يكون هذا مصحوبًا بانخفاض في<em> قدرتها على نقل الأكسجين (انخفاض الهيموجلوبين)</em></strong></p><p dir="RTL"><strong><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong><em>الخلايا الحمراء والخلايا البيضاء والصفائح الدموية في الوقت ذاته (</em></strong><strong>قلة الكريات الشاملة)</strong></p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong>تكون جلطات دموية صغيرة في الأوعية الدموية مما يعيق التدفق الطبيعي للدم في أجزاء الجسم (انتشار تخثر دم داخل الأوعية)</strong></p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong>متلازمة انحلال الدم اليوريمية - حالة تسبب فشل كلوي وانحلال غير طبيعي لخلايا الدم الحمراء وانخفاض عدد الصفائح الدموية في الدم.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>جهاز الغدد الصماء</strong></p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong>تورم المخ بسبب زيادة نسبة الماء في الدم <strong>(التسمم المائي).&nbsp; ومن علامات ذلك </strong>الصداع أو تغير في الشخصية أو السلوك أو الارتباك أو النعاس</p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong><em>زيادة في إفراز الهرمون المضاد لإدرار البول من الغدة النخامية.&nbsp; ويؤثر ذلك على الكلى، مما يتسبب في انخفاض مستويات الصوديوم في الدم (نقص صوديوم الدم) واحتباس الماء.</em></strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التمثيل الغذائي والتغذية</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستويات الصوديوم في الدم، مما يسبب التعب والارتباك وتشنج العضلات وحدوث نوبات وغيبوبة (نقص صوديوم الدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تراكم السوائل في الجسم (احتباس الماء)، والتي تظهر على شكل سائل موجود تحت الجلد أو تورم الأطراف</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع مستويات سكر الدم والذي قد يتسبب في عطش وتعب وتهيج (فرط سكر الدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستويات سكر الدم، والذي قد يسبب ارتباك وتعرق (نقص سكر الدم)</p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong>فقدان الشهية</strong></p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong>جفاف.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">الجهاز الهضمي</p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong>شعور بالإعياء والإصابة بالإعياء (غثيان وقيء).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأمعاء، والذي قد يسبب نزيف (التهاب الأمعاء، التهاب الأعور، <strong>التهاب معوي قولوني نزفي)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف في المعدة أو الأمعاء (<strong>نزيف معدي معوي)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم راحة في البطن أو شعور شديد بالامتلاء وألم في الظهر، قد يكون سببه التهاب البنكرياس (<strong>التهاب البنكرياس الحاد)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب يسبب ألم في المعدة أو إسهال (التهاب القولون)</p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong>إمساك أو إسهال</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>تقرحات في بطانة الجهاز الهضمي (تقرح الغشاء المخاطي)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب في بطانة الفم يشمل تقرحات (<strong>التهاب الفم)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>تورم الغدد في الرقبة (التهاب الغدة النكفية)</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاضطرابات النفسية</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>الارتباك</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجهاز العصبي</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>آثار على المخ (اعتلال دماغي)، ومن علاماته </strong>مشكلات في التفكير أو التركيز وقلة اليقظة وتغيرات في الشخصية وتعب ونوبات وتشنج العضلات وارتجاف</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبات (<strong>تشنجات)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>دوار</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>متلازمة تسمى متلازمة اعتلال بيضاء الدماغ الخلفي العكسي، والتي قد تسبب ورم المخ </strong>وصداع وارتباك ونوبات وفقدان البصر</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آثار على الحبل الشوكي (<strong>اعتلال النخاع)، والتي يمكن أن تسبب </strong>تنميل وضعف ووخز في اليدين وفقدان المهارات الحركية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>اضطراب الأعصاب، والذي قد يسبب ضعف ووخز أو تنميل (اعتلال الأعصاب المحيطية).&nbsp; قد يصيب هذا أكثر من مجموعة من الأعصاب (اعتلال الأعصاب المتعددة)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم نابع من الأعصاب، والذي يشبه أيضًا إحساس الوجع أو الحرقان (<strong>ألم عصبي)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وخز أو تنميل، وغالبًا ما يحدث في اليدين أو القدمين (<strong>مَذَل)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتجاف (رعشة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في حاسة اللمس (<strong>ضعف الحس) أو فقدان الإحساس (نقص الحس)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في حاسة التذوق (<strong>خلل الذوق) أو فقدان التذوق (نقص حاسة الذوق)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>تغيرات في حاسة الشم (خَطَلُ الشم).</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>العينان والأذنان</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تشوش الرؤية أو ضعف البصر أو فقدانه</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب العين (<strong>التهاب الملتحمة)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة إفراز الدموع (<strong>دمعان).</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصمم أو فقدان السمع</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طنين في الأذن (<strong>الطنين).</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">القلب والدورة الدموية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبة قلبية (<strong>احتشاء عَضَلة القلب)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في نبضات القلب (اضطراب النظم) والتي قد تكون ملحوظة (خفقان):</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نبضات قلب غير منتظمة (<strong>رجفان)</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>نبضات قلب سريعة (تسرع القلب)، والتي قد تهدد الحياة (تسرع القلب البطيني)</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نبضات قلب بطيئة (<strong>بطء ضربات القلب)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في قدرة القلب على ضخ دم كاف لجميع أجزاء الجسم والذي قد يهدد الحياة (صدمة قلبية أو فشل القلب أو توقف القلب)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مرض عضلة القلب (<strong>اعتلال عضلة القلب)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>التهاب الأنسجة في القلب أو حوله (التهاب عَضَلة القلب، التهاب التأمور)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &lrm;تكون سائل في الكيس الموجود حول القلب (<strong>انصباب تأموري).&nbsp; يمكن أن يسبب الضغط الزائد الناتج عن هذا السائل توقف امتلاء القلب بشكل سليم </strong>(<strong>دُكاك قلبي)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>رسم قلب غير طبيعي (تخطيط كهربائية القلب لمتلازمة كيو تي طويلة).</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; <strong>تجلط الدم في الرئتين والذي يسبب ألم في الصدر وضيق تنفس (انسداد رئوي)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; تجلط الدم، عادةً في إحدى القدمين، مما يسبب ألم أو تورم أو احمرار (<strong>خُثار وريدي)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأوعية الدموية (<strong>التهاب وعائي)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; <strong>ضعف في وصول الدم إلى اليدين والقدمين (نقص التروية المحيطية).&nbsp; قد يسبب هذا </strong>ألم أو ضعف أو تنميل أو تقرحات أو تغيرات في لون الجلد أو درجة الحرارة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض أو ارتفاع ضغط الدم (نقص ضغط الدم، فرط ضغط الدم)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احمرار الجلد (تورد) قد يكون مصحوبًا بشعور بالحرارة أو التعرق (تورد ساخن).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الرئتين</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف مهدد للحياة في قدرة الرئتين على نقل الأكسجين إلى الدم (فشل تنفسي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تجلط الدم في الرئتين، مما يسبب ألم في الصدر وضيق تنفس (<strong>مرض الانسداد الوريدي الرئوي)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تندب الرئتين، مما يسبب ضيق النفس (تليف رئوي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حالات تسبب التهاب الرئتين، مما قد يسبب ضيق التنفس أو سعال وارتفاع في درجة الحرارة أو تندب الرئتين (<strong>التهاب رئوي، متلازمة الضائقة التنفسية الحادة، التهاب القصيبات المسد، ذات الرئة المنظم، حساسية الأسناخ الرئوية)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تجمع سائل داخل أو حول الرئتين (وذمة الرئة، <strong>انصباب جَنْبِي)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع ضغط الدم في الرئتين، مما قد يسبب ضيق النفس أو إجهاد أو سعال أو ذبحة أو إغماء أو وذمة محيطية (ارتفاع ضغط الدم الرئوي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (صعوبة في التنفس أو أزيز في الصدر (تشنج قصبي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق النفس (<strong>زُلَّة)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مستويات الأكسجين في الدم (<strong>نقص التأكسج)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>سعال</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انسداد أو رشح الأنف</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في الجزء الخلفي من الحلق.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الكبد</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة حجم الكبد (تضخم الكبد)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اصفرار الجلد أو ابيضاض العيون (يرقان)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انسداد الأوردة الصغيرة في الكبد (<strong>مرض انسداد الوريد الكبدي</strong>)، والذي قد يسبب زيادة في الوزن وزيادة في حجم الكبد وألم ويرقان</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حالات تسبب التهاب الكبد والذي يتسبب في يرقان وفقدان الوزن ووعكة (التهاب كبدي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب في إفراز الصفراء بواسطة الكبد، مما قد يسبب حكة ويرقان وشحوب لون البراز وغمقان لون البول (<strong>ركود صفراوي)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تراكم السموم في الجسم نتيجة لفشل الكبد (<strong>تسمم الكبد).&nbsp; قد يؤثر هذا على المخ ويتسبب في ارتباك وضعف الوعي أو غيبوبة (اعتلال دماغي كبدي)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تراكم سوائل في البطن، مما يسبب تورم البطن وضيق التنفس (<strong>استسقاء)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع مستويات بروتينات معينة يفرزها الكبد تسمى الإنزيمات.&nbsp; سيقوم طبيبك بإجراء اختبارات دم للتحقق من وجودها.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجلد والأنسجة تحت الجلد</strong></p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong><em>حالات تهدد الحياة تسبب طفح جلدي أو تقرحات والتهاب الحلق وحمى والتهاب الملتحمة وانفصال طبقات الجلد (</em></strong><strong>تقشر الأنسجة المُتموتة البَشروية التسممي<em>، </em>متلازمة ستيفنز جونسون)</strong></p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong>تورم وتنميل وكتلات حمراء وتقشر الجلد في اليدين والقدمين (<strong>متلازمة ضعف الحس الاحمراري الراحي الأخمصي)</strong></p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong><em>طفح جلدي مرتفع ذو لون أحمر والذي يسبب حكة (</em></strong><strong>الشرى)</strong></p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong><em>التهاب الجلد، والذي قد يسبب طفح جلدي ونفطات وحكة وقروح وارتشاح وتندب (</em></strong><strong>التهاب الجلد)</strong></p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong>احمرار ونفطات الجلد تستمر لشهور أو أعوام بعد العلاج (<strong>التهاب الجلد الناتج عن التعرض للإشعاع)</strong></p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong><em>طفح جلدي أحمر اللون يسبب حكة قد يتفاقم إلى تقرحات (</em></strong><strong>حُمامي عديد الأشكال)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في لون الأظافر والجلد.</p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong><em>انفصال قاع الظفر، مما قد يسبب تساقط الأظافر</em></strong></p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong><em>جفاف</em></strong></p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong><em>تعرق مفرط (فرط التعرق)</em></strong></p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong><em>تورم الوجه</em></strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>تساقط الشعر (ثعلبة).</em></strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجهاز العضلي الهيكلي والأنسجة الضامة</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انحلال غير طبيعي للعضلات مما قد يؤدي إلى حدوث مشكلات في الكلى (<strong>انحلال الرُبيدات)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مرض خطير قد يتسبب في زيادة سمك الجلد والأنسجة الضامة في الأعضاء الداخلية (<strong>تصلب الجلد)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>تشنج العضلات</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم العضلات (<strong>ألم عضلي</strong>) أو <strong>ألم المفاصل (ألم مفصلي)</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الكلى والجهاز البولي</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض مهدد للحياة في قدرات الكلى على إخراج السموم والفضلات من الدم بشكلٍ كافٍ (الفشل الكلوي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في الأنسجة داخل الكلى، مما قد يحول دون القيام بوظيفتها على النحو الصحيح (<strong>نخر نُبيبي كلوي، اضطراب نُبيبي كلوي)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>تضرر الكلى بالسموم الموجودة في الدم (اعتلال الكلية السام)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>ألم وصعوبة في التبول (التهاب المثانة)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وجود دم في البول (<strong>بِيلة دموية)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>وجود جلوكوز في البول (البُوالة التَفِهة الكلوية المنشأ)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب بطانة المثانة، مما يسبب ألم ونزيف ونزول دم في البول وقلة تدفق البول (<strong>التهاب مثانة نزفي)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>التهاب في مجرى البول يسبب ألم ونزيف. (التهاب الحالب النزفي)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>موت الخلايا والأنسجة (نخر) أو تقرحات وتندب (تليف) المثانة</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في حجم المثانة (<strong>تقفُع المثانة)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في الخلايا المبطنة للمثانة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>زيادة في مستويات الكرياتينين أو نيتروجين اليوريا في الدم.&nbsp; </strong>سيقوم طبيبك بإجراء اختبارات دم للتحقق من وجودها.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والخصوبة</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الولادة المبكرة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>العقم.&nbsp; قد يقل أو يتوقف إنتاج الحيوانات المنوية لدى الرجال وإنتاج البويضات لدى النساء.&nbsp; في بعض الحالات قد يصبح هذا الوضع دائم</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انعدام الطمث <strong>(انقطاع الحيض) أو </strong>قلة مرات الحيض (<strong>قلة الطمث)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في حجم الخصية (<strong>ضمور الخصية)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في هرمون الإستروجين في الدم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في هرمون <strong>موجِهة للغدد التناسلية في الدم</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يؤدي الاستخدام مع المرضى الشباب إلى فقدان الخصوبة في المستقبل.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاضطرابات الخلقية والعائلية والوراثية</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نقص النمو أو حدوث تشوه أو وفاة الأجنة بداخل الرحم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الآثار السامة على الأجنة، مثل <strong>كبت نخاع العظم</strong> والتهاب المعدة والأمعاء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اضطرابات عامة وحالات في موضع الإعطاء</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فشل في عدد من الأعضاء يهدد الحياة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>تدهور بدني عام</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أعراض تشبه الإنفلونزا، مثل صداع وحمى ورعشة وألم في المفاصل والعضلات وضعف وتعب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم الصدر</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات في موضع الحقن/التسريب مثل التورم والاحمرار والألم والالتهاب وتضرر الأنسجة وموتها وتكون الجلطات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب البطانة في تجاويف الجسم (التهاب الأغشية المخاطية).</p><p dir="RTL">&nbsp;</p><p dir="RTL">الإبلاغ عن الآثار الجانبية</p><p dir="RTL"><strong>في حالة تعرضك لأي آثار جانبية، تحدث إلى الطبيب أو الصيدلي أو الممرضة. ويشمل هذا أي آثار جانبية محتملة غير واردة في هذه النشرة. يمكنك أيضًا الإبلاغ مباشرة عن الآثار الجانبية (انظر التفاصيل أدناه). من خلال الإبلاغ عن الآثار الجانبية يمكنك المساعدة في توفير المزيد من المعلومات بشأن سلامة هذا الدواء.</strong></p><p dir="RTL">&nbsp;</p><ul><li dir="RTL">المملكة العربية السعودية:</li></ul><p dir="RTL">&nbsp;</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المركز الوطني للتيقظ والسلامة الدوائية (NPC)</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فاكس: +966-11-205-7662</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اتصل بالمركز على رقم +966-11-2038222، داخلي: 2317-2356-2353-2354-2334-2340.</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رقم الهاتف المجاني: 8002490000</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa&nbsp;</p><p dir="RTL">&sect;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: www.sfda.gov.sa/npc&nbsp;</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><ul><li dir="RTL">دول مجلس التعاون الخليجي الأخرى:</li></ul><p dir="RTL">&nbsp;</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرجاء الاتصال بالهيئة المختصة.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">بما أنه عادةً ما يتم إعطاء دواء سيكلوفوسفاميد في المستشفى، فسوف يتم تخزينه بطريقة آمنة وصحيحة بواسطة موظفي المستشفى. إذا كنت بحاجة إلى شروط التخزين ستجدها فيما يلي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ بعيدًا عن متناول ومرأى الأطفال.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم دواء سيكلوفوسفاميد بعد تاريخ انتهاء الصلاحية المدون على الملصق بعد كلمة &quot;EXP&quot;. يشير تاريخ انتهاء الصلاحية إلى آخر يوم من الشهر المذكور.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يُخزن في درجات حرارة تزيد عن 25 درجة مئوية. يُخزن في عبوته الأصلية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ما هي</strong> محتويات<strong> دواء سيكلوفوسفاميد&rlm;</strong><strong>&lrm;</strong></p><p dir="RTL">المادة الفعالة هي سيكلوفوسفاميد&rlm;&lrm; وتحتوي كل قنينة على:</p><p dir="RTL">200 ملجم أو 500 ملجم أو 1000 ملجم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">ليس هناك مكونات أخرى في الدواء.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ما هو </strong>شكل<strong> دواء سيكلوفوسفاميد وما هي محتويات العبوة</strong></p><p dir="RTL"><strong>سيكلوفوسفاميد هو عبارة عن مسحوق أبيض جاف موجود داخل قنينات زجاجية شفافة. تحتوي كل علبة كرتونية على قنينة واحدة.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">طبيعة ومحتويات الحاوية</p><p dir="RTL">يتم توفير القنينات داخل غلاف بلاستيكي واقي أو بدونه. لا يلمس الغلاف البلاستيكي الواقي المستحضر الطبي ويوفر حماية إضافية أثناء النقل، مما يزيد من السلامة للأشخاص العاملين في المجال الطبي والصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="ltr" style="text-align:left">Baxter Oncology GmbH</p><p dir="ltr" style="text-align:left">Kantstra&szlig;e 2</p><p dir="ltr" style="text-align:left">33790&nbsp;Halle/Westfalen</p><p dir="ltr" style="text-align:left">Germany</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            إبريل 2016
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cyclophosphamide Injection 500 mg
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each vial contains cyclophosphamide monohydrate equivalent to 500 mg anhydrous cyclophosphamide.

When reconstituted for intravenous use, the solution for administration contains 20 mg cyclophosphamide per ml.

Throughout this Summary of Product Characteristics, Endoxan Injection 500 mg will be called Cyclophosphamide.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder for solution for injection.

A white crystalline powder contained in clear glass injection vials.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cyclophosphamide is a cytotoxic drug for the treatment of malignant disease in adults and children.&nbsp; As a single agent, it has successfully produced an objective remission in a wide range of malignant conditions.&nbsp; Cyclophosphamide is also frequently used in combination with other cytotoxic drugs, radiotherapy or surgery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cyclophosphamide Injection is for intravenous or oral administration.</p><p>&nbsp;</p><p>Cyclophosphamide should only be used by clinicians experienced in the use of cancer chemotherapy.&nbsp; Cyclophosphamide should only be administered where there are facilities for regular monitoring of clinical, biochemical and haematological parameters before, during, and after administration and under the direction of a specialist oncology service.</p><p><strong>Posology</strong></p><p>Dosage must be individualized.&nbsp; Doses and duration of treatment and/or treatment intervals depend on the therapeutic indication, the scheme of a combination therapy, the patient&rsquo;s general state of health and organ function, and the results of laboratory monitoring (in particular, blood cell monitoring).</p><p>A guide to the dosage regimens used for most indications is given below.</p><p>This treatment should be continued until a clear remission or improvement is seen or be interrupted when the extent of leucopenia becomes unacceptable.</p><p>Conventional: 80-300 mg/m&sup2; daily as a single i.v. dose or daily divided oral doses.&nbsp;<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 300-600 mg/m&sup2; as a single i.v. dose weekly.</p><p>High dose:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 600 - 1500 mg/m&sup2; as a single i.v. dose or short infusion given at<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 10-20 day intervals.</p><p>In combination with other cytostatics of similar toxicity, a dose reduction or extension of the therapy-free intervals may be necessary.</p><p>Activation of cyclophosphamide requires hepatic metabolism; therefore, oral and intravenous administrations are preferred.</p><p>Use of hematopoiesis stimulating agents (colony-stimulating factors and erythropoiesis stimulating agents) may be considered to reduce the risk of myelosuppressive complications and/or help facilitate the delivery of the intended dosing.</p><p>During or immediately after the administration, adequate amounts of fluid should be ingested or infused to force diuresis in order to reduce the risk of urinary tract toxicity. Therefore, cyclophosphamide should be administered in the morning. See Section 4.4.</p><p>To reduce the likelihood of adverse reactions that appear to be administration rate-dependent (e.g., facial swelling, headache, nasal congestion, scalp burning), cyclophosphamide should be injected or infused very slowly.</p><p><u>Patients with Hepatic Impairment</u></p><p>Severe hepatic impairment may be associated with decreased activation of cyclophosphamide. This may alter the effectiveness of cyclophosphamide treatment and should be considered when selecting the dose and interpreting response to the dose selected.</p><p><u>Patients with Renal Impairment</u></p><p>In patients with renal impairment, particularly in patients with severe renal impairment, decreased renal excretion may result in increased plasma levels of cyclophosphamide and its metabolites. This may result in increased toxicity and should be considered when determining the dosage in such patients.</p><p>Cyclophosphamide and its metabolites are dialyzable, although there may be differences in clearance depending upon the dialysis system being used. In patients requiring dialysis, use of a consistent interval between cyclophosphamide administration and dialysis should be considered. See Section 4.4.</p><p><u>Elderly</u></p><p>In elderly patients, monitoring for toxicities and the need for dose adjustment should reflect the higher frequency of decreased hepatic, renal, cardiac, or other organ function, and concomitant diseases or other drug therapy in this population.</p><p><u>&nbsp;</u></p><p><u>Children</u></p><p>No specific information.&nbsp; Children have received Cyclophosphamide.&nbsp; No adverse reactions specific to this group have been reported.</p><p><u>Method of Administration</u></p><p>Cyclophosphamide is inert until activated by enzymes in the liver.&nbsp; However, as with all cytotoxics, it is suggested that reconstitution should be performed by trained personnel, in a designated area.</p><p>Those handling the preparation should wear protective gloves.&nbsp; Care should be taken to avoid splashing material into the eyes.&nbsp; The material should not be handled by women who are pregnant or who are breast-feeding.</p><p><em>Intravenous administration</em></p><p>Intravenous administration preferably should be conducted as an infusion, usually given directly into the tubing of a fast running i.v. infusion with the patient supine.&nbsp; Care should be taken that extravasation does not take place, however, should it occur, no specific measures need be taken.</p><p>Duration of the infusion also should be appropriate for the volume and type of carrier fluid to be infused.&nbsp;</p><p>If injected directly, cyclophosphamide for parenteral administration should be reconstituted with physiological saline (0.9% sodium chloride), see section 6.6. <strong>&nbsp;</strong>The pH of an aqueous solution is between 4 and 6.&nbsp;</p><p>Cyclophosphamide, reconstituted in water, is hypotonic and should not be injected directly.&nbsp; For infusion, cyclophosphamide should be reconstituted by adding sterile water and infused in the recommended intravenous solutions.</p><p>Before parenteral administration, the substance must be completely dissolved.</p><p>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.</p><p><em>Oral administration</em></p><p>For oral use, an elixir may be prepared by dissolving the dry powder in Aromatic Elixir USP.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cyclophosphamide is contra-indicated in patients with:

•	hypersensitivity to cyclophosphamide or to any of its metabolites. 
•	acute infections, 
•	bone-marrow aplasia, 
•	urinary tract infection 
•	acute urothelial toxicity from cytotoxic chemotherapy or radiation therapy
•	Urinary outflow obstruction.

Cyclophosphamide should not be used in the management of non-malignant disease, except for immunosuppression in life-threatening situations.

Cyclophosphamide is contra-indicated during pregnancy. See section 4.4 and 4.6.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>WARNINGS</strong></p><p><u>Anaphylactic Reactions, Cross-sensitivity with Other Alkylating Agents</u></p><p>Anaphylactic reactions including those with fatal outcomes have been reported in association with cyclophosphamide.</p><p>Possible cross-sensitivity with other alkylating agents has been reported.</p><p><u>Myelosuppression, Immunosuppression, Infections</u></p><p>Treatment with cyclophosphamide may cause myelosuppression and significant suppression of immune responses.</p><p>Cyclophosphamide-induced myelosuppression can cause leukopenia, neutropenia, thrombocytopenia (associated with a higher risk of bleeding events), and anaemia.</p><p>Severe immunosuppression has lead to serious, sometimes fatal, infections. Sepsis and septic shock have also been reported. Infections reported with cyclophosphamide include pneumonias, as well as other bacterial, fungal, viral, protozoal, and parasitic infections.</p><p>Latent infections can be reactivated. Reactivation has been reported for various bacterial, fungal, viral, protozoal, and parasitic infections.</p><p>Infections must be treated appropriately.</p><p>Antimicrobial prophylaxis may be indicated in certain cases of neutropenia at the discretion of the managing physician.</p><p>In case of neutropenic fever, antibiotics and/or antimycotics must be given.</p><p>Cyclophosphamide should be used with caution, if at all, in patients with severe impairment of bone marrow function and in patients with severe immunosuppression.</p><p>Unless essential, cyclophosphamide should not be administered to patients with a leukocyte count below 2500 cells/microlitre (cells/ mm3 and/or a platelet count below 50,000 cells/microlitre (cells/mm3).</p><p>Cyclophosphamide treatment may not be indicated, or should be interrupted, or the dose reduced, in patients who have or who develop a serious infection.</p><p>In principle, the fall in the peripheral blood cell and thrombocyte count and the time taken to recover may increase with increasing doses of cyclophosphamide.</p><p>The nadirs of the reduction in leukocyte count and thrombocyte count are usually reached in weeks 1 and 2 of treatment. The bone marrow recovers relatively quickly, and the levels of peripheral blood cell counts normalize, as a rule, after approximately 20 days.</p><p>Severe myelosuppression must be expected particularly in patients pretreated with and/or receiving concomitant chemotherapy and/or radiation therapy.</p><p>Close haematological monitoring is required for all patients during treatment.</p><p><u>Urinary Tract and Renal Toxicity</u></p><p>Hemorrhagic cystitis, pyelitis, ureteritis, and haematuria have been reported with cyclophosphamide therapy. Bladder ulceration/necrosis, fibrosis/contracture and secondary cancer may develop.</p><p>Urotoxicity may mandate interruption of treatment.</p><p>Cystectomy may become necessary due to fibrosis, bleeding, or secondary malignancy.</p><p>Cases of urotoxicity with fatal outcomes have been reported.</p><p>Urotoxicity can occur with short-term and long-term use of cyclophosphamide. Hemorrhagic cystitis after single doses of cyclophosphamide has been reported.</p><p>Past or concomitant radiation or busulfan treatment may increase the risk for cyclophosphamide-induced hemorrhagic cystitis.</p><p>Cystitis is, in general, initially abacterial. Secondary bacterial colonization may follow.</p><p>Before starting treatment, it is necessary to exclude or correct any urinary tract obstructions. See Section 4.3.</p><p>Urinary sediment should be checked regularly for the presence of erythrocytes and other signs of uro/nephrotoxicity.</p><p>Cyclophosphamide should be used with caution, if at all, in patients with active urinary tract infections.</p><p>Adequate treatment with mesna and/or strong hydration to force dieresis can markedly reduce the frequency and severity of bladder toxicity. It is important to ensure that patients empty the bladder at regular intervals.</p><p>Hematuria usually resolves in a few days after cyclophosphamide treatment is stopped, but it may persist.</p><p>It is usually necessary to discontinue cyclophosphamide therapy in instances of severe hemorrhagic cystitis.</p><p>Cyclophosphamide has also been associated with nephrotoxicity, including renal tubular necrosis.</p><p>Hyponatremia associated with increased total body water, acute water intoxication, and a syndrome resembling SIADH (syndrome of inappropriate secretion of antidiuretic hormone) have been reported in association with cyclophosphamide administration. Fatal outcomes have been reported.</p><p><u>Cardiotoxicity, Use in Patients with Cardiac Disease</u></p><p>Myocarditis and myopericarditis, which may be accompanied by significant pericardial effusion and cardiac tamponade, have been reported with cyclophosphamide therapy and have led to severe, sometimes fatal congestive heart failure.</p><p>Histopathologic examination has primarily shown hemorrhagic myocarditis. Haemopericardium has occurred secondary to hemorrhagic myocarditis and myocardial necrosis.</p><p>Acute cardiac toxicity has been reported with a single dose of less than 2mg/kg cyclophosphamide.</p><p>Following exposure to treatment regimens that included cyclophosphamide, supraventricular arrhythmias (including atrial fibrillation and flutter) as well as ventricular arrhythmias (including severe QT prolongation associated with ventricular tachyarrhythmia) have been reported in patients with and without other signs of cardiotoxicity.</p><p>The risk of cyclophosphamide cardiotoxicity may be increased for example, following high doses of cyclophosphamide, in patients with advanced age, and in patients with previous radiation treatment of the cardiac region and/or previous or concomitant treatment with other cardiotoxic agents. See Section 4.5.</p><p>Particular caution is necessary in patients with risk factors for cardiotoxicity and in patients with pre-existing cardiac disease.</p><p><u>&nbsp;</u></p><p><u>Pulmonary Toxicity</u></p><p>Pneumonitis and pulmonary fibrosis have been reported during and following treatment with cyclophosphamide. Pulmonary veno-occlusive disease and other forms of pulmonary toxicity have also been reported.</p><p>Pulmonary toxicity leading to respiratory failure has been reported.</p><p>While the incidence of cyclophosphamide-associated pulmonary toxicity is low, prognosis for affected patients is poor.</p><p>Late onset of pneumonitis (greater than 6 months after start of cyclophosphamide) appears to be associated with a particularly high mortality. Pneumonitis may develop even years after treatment with cyclophosphamide.</p><p>Acute pulmonary toxicity has been reported after a single cyclophosphamide dose.</p><p><u>Secondary Malignancies</u></p><p>As with all cytotoxic therapy, treatment with cyclophosphamide involves the risk of secondary tumours and their precursors as late sequelae.</p><p>The risk of urinary tract cancer as well as the risk of myelodysplastic alterations, partly progressing to acute leukemias, is increased. Other malignancies reported after use of cyclophosphamide or regimens with cyclophosphamide include lymphoma, thyroid cancer, and sarcomas.</p><p>In some cases, the second malignancy developed several years after cyclophosphamide treatment had been discontinued. Malignancy has also been reported after <em>in utero</em> exposure.</p><p><u>Veno-occlusive Liver Disease</u></p><p>Veno-occlusive liver disease (VOLD) has been reported in patients receiving cyclophosphamide.</p><p>A cytoreductive regimen in preparation for bone marrow transplantation that consists of cyclophosphamide in combination with whole-body irradiation, busulfan, or other agents has been identified (see Section 4.5) as a major risk factor for the development of VOLD. After cytoreductive therapy, the clinical syndrome typically develops 1 to 2 weeks after transplantation and is characterized by sudden weight gain, painful hepatomegaly, ascites, and hyperbilirubinemia/jaundice.</p><p>However, VOLD has also been reported to develop gradually in patients receiving long-term low-dose immunosuppressive doses of cyclophosphamide.</p><p>As a complication of VOLD, hepatorenal syndrome and multiorgan failure may develop. Fatal outcome of cyclophosphamide-associated VOLD has been reported.</p><p>Risk factors predisposing a patient to the development of VOLD with high-dose cytoreductive therapy include:</p><p>&ndash; preexisting disturbances of hepatic function,<br />&ndash; previous radiation therapy of the abdomen, and a<br />&ndash; low performance score.</p><p><u>Genotoxicity</u></p><p>Cyclophosphamide is genotoxic and mutagenic, both in somatic and in male and female germ cells. Therefore, women should not become pregnant and men should not father a child during therapy with cyclophosphamide.<br /><br />Both women and men should wait at least 6 to 12 months after stopping Cyclophosphamide before attempting to conceive or father a child.</p><p>Animal data indicate that exposure of oocytes during follicular development may result in a decreased rate of implantations and viable pregnancies, and in an increased risk of malformations. This effect should be considered in case of intended fertilization or pregnancy after discontinuation of cyclophosphamide therapy. The exact duration of follicular development in humans is not known, but may be longer than 12 months.</p><p>Sexually active women and men should use effective methods of contraception during these periods of time.</p><p>Fertility, see section 4.6.</p><p><u>Impairment of Wound Healing</u></p><p>Cyclophosphamide may interfere with normal wound healing.</p><p><strong>PRECAUTIONS</strong></p><p><u>Alopecia</u></p><p>Alopecia has been reported and may occur more commonly with increasing doses.</p><p>Alopecia may progress to baldness.</p><p>The hair can be expected to grow back after treatment with the drug or even during continued drug treatment, though it may be different in texture or colour.</p><p><u>Nausea and Vomiting</u></p><p>Administration of cyclophosphamide may cause nausea and vomiting.</p><p>Current guidelines on the use of antiemetics for prevention and amelioration of nausea and vomiting should be considered.</p><p>Alcohol consumption may increase cyclophosphamide-induced vomiting and nausea.</p><p><u>Stomatitis</u></p><p>Administration of cyclophosphamide may cause stomatitis (oral mucositis).</p><p>Current guidelines on measures for prevention and amelioration of stomatitis should be considered.</p><p><u>Paravenous Administration</u></p><p>The cytostatic effect of cyclophosphamide occurs after its activation, which takes place mainly in the liver. Therefore, the risk of tissue injury from accidental paravenous administration is low.</p><p>In case of accidental paravenous administration of cyclophosphamide, the infusion should be stopped immediately, the extravascular cyclophosphamide solution should be aspirated with the cannula in place, and other measures should be instituted as appropriate.</p><p><u>Use in Patients with Renal Impairment</u></p><p>In patients with renal impairment, particularly in patients with severe renal impairment, decreased renal excretion may result in increased plasma levels of cyclophosphamide and its metabolites. This may result in increased toxicity and should be considered when determining the dosage in such patients. See Section 4.2.</p><p><u>Use in Patients with Hepatic Impairment</u></p><p>Severe hepatic impairment may be associated with decreased activation of cyclophosphamide. This may alter the effectiveness of cyclophosphamide treatment and should be considered when selecting the dose and interpreting response to the dose selected.</p><p><u>Use in Adrenalectomized Patients</u></p><p>Patients with adrenal insufficiency may require an increase in corticoid substitution dose when exposed to stress from toxicity due to cytostatics, including cyclophosphamide.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Planned coadministration or sequential administration of other substances or treatments that could increase the likelihood or severity of toxic effects (by means of pharmacodynamic or pharmacokinetic interactions) requires careful individual assessment of the expected benefit and the risks.</p><p>Patients receiving such combinations must be monitored closely for signs of toxicity to permit timely intervention. Patients being treated with cyclophosphamide and agents that reduce its activation should be monitored for a potential reduction of therapeutic effectiveness and the need for dose adjustment.</p><p><u>Interactions Affecting the Pharmacokinetics of Cyclophosphamide and its Metabolites</u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduced activation of cyclophosphamide may alter the effectiveness of cyclophosphamide treatment. Substances that delay activation of cyclophosphamide include:</p><p>&ndash;&nbsp; Aprepitant</p><p>&ndash;&nbsp; Bupropion</p><p>&ndash;&nbsp; Busulfan: Cyclophosphamide clearance has been reported to be reduced and half-life prolonged in patients who receive high-dose cyclophosphamide less than 24 hours after high-dose busulfan.</p><p>&ndash;&nbsp; Ciprofloxacin: When given prior to the treatment with cyclophosphamide (used for conditioning prior to bone marrow transplantation), ciprofloxacin has been reported to result in a relapse of the underlying disease.</p><p>&ndash;&nbsp; Chloramphenicol</p><p>&ndash;&nbsp; Fluconazole</p><p>&ndash;&nbsp; Itraconazole</p><p>&ndash;&nbsp; Prasugrel</p><p>&ndash; Sulfonamides</p><p>&ndash;&nbsp; Thiotepa: A strong inhibition of cyclophosphamide bioactivation by thiotepa in high-dose chemotherapy regimens has been reported when thiotepa was administered 1 hour prior to cyclophosphamide.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An increase of the concentration of cytotoxic metabolites may occur with:</p><p>&ndash;&nbsp; Allopurinol</p><p>&ndash;&nbsp; Chloral hydrate</p><p>&ndash;&nbsp; Cimetidine</p><p>&ndash;&nbsp; Disulfiram</p><p>&ndash;&nbsp; Glyceraldehyde</p><p>&ndash;&nbsp; Inducers of human hepatic and extrahepatic microsomal enzymes (e.g., cytochrome P450 enzymes): The potential for hepatic and extrahepatic microsomal enzyme induction must be considered in case of prior or concomitant treatment with substances known to induce an increased activity of such enzymes such as rifampin, phenobarbital, carbamazepine, phenytoin, St. John&rsquo;s wort, and corticosteroids.</p><p>&ndash;&nbsp; Protease inhibitors: Concomitant use of protease inhibitors may increase the concentration of cytotoxic metabolites. Use of protease inhibitor-based regimens was found to be associated with a higher incidence of infections and neutropenia in patients receiving cyclophosphamide, doxorubicin, and etoposide (CDE) than use of an NNRTI-based regimen.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ondansetron</p><p>There have been reports of a pharmacokinetic interaction between ondansetron and high-dose cyclophosphamide resulting in decreased cyclophosphamide AUC.</p><p><u>Pharmacodynamic Interactions and Interactions of Unknown Mechanism Affecting the Use of Cyclophosphamide</u></p><p>Combined or sequential use of cyclophosphamide and other agents with similar toxicities can cause combined (increased) toxic effects.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased hematotoxicity and/or immunosuppression may result from a combined effect of cyclophosphamide and, for example</p><p>&ndash;&nbsp; ACE inhibitors: ACE inhibitors can cause leukopenia.</p><p>&ndash;&nbsp; Natalizumab</p><p>&ndash;&nbsp; Paclitaxel: Increased hematotoxicity has been reported when cyclophosphamide was administered after paclitaxel infusion.</p><p>&ndash;&nbsp; Thiazide diuretics</p><p>&ndash;&nbsp; Zidovudine</p><p>&ndash;&nbsp; Clozapine</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased cardiotoxicity may result from a combined effect of cyclophosphamide and, for example</p><p>&ndash; Anthracyclines</p><p>&ndash; Cytarabine</p><p>&ndash; Pentostatin</p><p>&ndash; Radiation therapy of the cardiac region</p><p>&ndash; Trastuzumab</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased pulmonary toxicity may result from a combined effect of cyclophosphamide and, for example</p><p>&ndash; Amiodarone</p><p>&ndash; G-CSF, GM-CSF (granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor): Reports suggest an increased risk of pulmonary toxicity in patients treated with cytotoxic chemotherapy that includes cyclophosphamide and G-CSF or GMCSF.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased nephrotoxicity may result from a combined effect of cyclophosphamide and, for example</p><p>&ndash; Amphotericin B</p><p>&ndash; Indomethacin: Acute water intoxication has been reported with concomitant use of indomethacin.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase in other toxicities</p><p>&ndash; Azathioprine: Increased risk of hepatotoxicity (liver necrosis)</p><p>&ndash; Busulfan: Increased incidence of hepatic veno-occlusive disease and mucositis has been reported.</p><p>&ndash; Protease inhibitors: Increased incidence of mucositis.</p><p><u>Other interactions</u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Alcohol</p><p>A reduced antitumor activity was observed in tumor-bearing animals during ethanol (alcohol) consumption and concomitant oral low-dose cyclophosphamide medication.</p><p>In some patients, alcohol may increase cyclophosphamide-induced vomiting and nausea.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Etanercept</p><p>In patients with Wegener&rsquo;s granulomatosis, the addition of etanercept to standard treatment, including cyclophosphamide, was associated with a higher incidence of non-cutaneous solid malignancies.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Metronidazole</p><p>Acute encephalopathy has been reported in a patient receiving cyclophosphamide and metronidazole. Causal association is unclear.</p><p>In an animal study, the combination of cyclophosphamide with metronidazole was associated with increased cyclophosphamide toxicity.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tamoxifen</p><p>Concomitant use of tamoxifen and chemotherapy may increase the risk of thromboembolic complications.<br />&nbsp;</p><p><u>Interactions Affecting the Pharmacokinetics and/or Actions of Other Drugs</u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bupropion</p><p>Cyclophosphamide metabolism by CYP2B6 may inhibit bupropion metabolism.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Coumarins</p><p>Both increased and decreased warfarin effect have been reported in patients receiving warfarin and cyclophosphamide.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cyclosporine</p><p>Lower serum concentrations of cyclosporine have been observed in patients receiving a combination of cyclophosphamide and cyclosporine than in patients receiving only cyclosporine. This interaction may result in an increased incidence of graft-versus-host disease.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depolarizing muscle relaxants</p><p>Cyclophosphamide treatment causes a marked and persistent inhibition of cholinesterase activity. Prolonged apnea may occur with concurrent depolarizing muscle relaxants (e.g., succinylcholine). If a patient has been treated with cyclophosphamide within 10 days of general anesthesia, the anesthesiologist should be alerted.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Digoxin, &beta;-acetyldigoxin</p><p>Cytotoxic treatment has been reported to impair intestinal absorption of digoxin and &beta;-acetyldigoxin tablets.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vaccines</p><p>The immunosuppressive effects of cyclophosphamide can be expected to reduce the response to vaccination. Use of live vaccines may lead to vaccine-induced infection.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Verapamil</p><p>Cytotoxic treatment has been reported to impair intestinal absorption of orally administered verapamil</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>Cyclophosphamide is contraindicated in pregnancy (see section 4.3). Cyclophosphamide crosses the placental barrier. Treatment with cyclophosphamide has a genotoxic effect and may cause foetal damage when administered to pregnant women. Both women and men should wait at least 6 to 12 months after stopping Cyclophosphamide before attempting to conceive or father a child.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Malformations have been reported in children born to mothers treated with cyclophosphamide during the first trimester of pregnancy. However, there are also reports of children without malformations born to women exposed during the first trimester.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exposure to cyclophosphamide in utero may cause miscarriage, foetal growth retardation, and foetotoxic effects manifesting in the newborn, including leukopenia, anaemia, pancytopenia, severe bone marrow hypoplasia, and gastroenteritis.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Animal data suggest that an increased risk of failed pregnancy and malformations may persist after discontinuation of cyclophosphamide as long as oocytes/follicles exist that were exposed to cyclophosphamide during any of their maturation phases. See Section 4.4, Genotoxicity.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If cyclophosphamide is used during pregnancy, or if the patient becomes pregnant while taking this drug or after treatment (see Section 4.4, Genotoxicity), the patient should be apprised of the potential hazard to a foetus.</p><p><u>Breastfeeding</u></p><p>Cyclophosphamide is passed into the breast milk. Neutropenia, thrombocytopenia, low hemoglobin, and diarrhoea have been reported in children breast fed by women treated with cyclophosphamide. Women must not breastfeed during treatment with cyclophosphamide.</p><p><u>Fertility</u></p><p>Cyclophosphamide interferes with oogenesis and spermatogenesis. It may cause sterility in both sexes.</p><p>Development of sterility appears to depend on the dose of cyclophosphamide, duration of therapy, and the state of gonadal function at the time of treatment.</p><p>Cyclophosphamide-induced sterility may be irreversible in some patients.</p><p>Sexually active women and men should use effective methods of contraception during these periods of time.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Female patients</p><p>Amenorrhea, transient or permanent, associated with decreased oestrogen and increased gonadotrophin secretion develops in a significant proportion of women treated with cyclophosphamide.</p><p>For older women, in particular, amenorrhea may be permanent.</p><p>Oligomenorrhea has also been reported in association with cyclophosphamide treatment.</p><p>Girls treated with cyclophosphamide during prepubescence generally develop secondary sexual characteristics normally and have regular menses.</p><p>Girls treated with cyclophosphamide during prepubescence subsequently have conceived.</p><p>Girls treated with cyclophosphamide who have retained ovarian function after completing treatment are at increased risk of developing premature menopause (cessation of menses before age of 40 years).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Male patients</p><p>Men treated with cyclophosphamide may develop oligospermia or azoospermia, which are normally associated with increased gonadotrophin but normal testosterone secretion.</p><p>Sexual potency and libido generally are unimpaired in these patients.</p><p>Boys treated with cyclophosphamide during prepubescence may develop secondary sexual characteristics normally, but may have oligospermia or azoospermia.</p><p>Some degree of testicular atrophy may occur.</p><p>Cyclophosphamide-induced azoospermia is reversible in some patients, though the reversibility may not occur for several years after cessation of therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients undergoing treatment with cyclophosphamide may experience undesirable effects (including, e.g., dizziness, blurred vision, visual impairment) which could affect the ability to drive or use machines. The decision to drive or operate machinery should be made on an individual basis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ADR frequency is based upon the following scale: Very Common (&ge;1/10); Common (&ge;1/100 - &lt;1/10), Uncommon (&ge;1/1,000 - &lt;1/100), Rare (&ge;1/10,000 - &lt;1/1,000), Very Rare (&lt;1/10,000), Unknown (adverse reactions reported in the post-marketing experience)</p><p>&nbsp;</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:616px"><thead><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Preferred term</strong></p></td><td style="vertical-align:top"><p><strong>Frequency</strong></p></td></tr></thead><tbody><tr><td style="vertical-align:top"><p>Infections and infestations</p></td><td style="vertical-align:top"><p>Infections<sup>1</sup></p><p>Pneumonia<sup>2</sup></p><p>Sepsis<sup>1 </sup></p><p>Septic shock</p></td><td style="vertical-align:top"><p>Common</p><p>Uncommon</p><p>Uncommon</p><p>Not Known</p></td></tr><tr><td style="vertical-align:top"><p>Neoplasms benign, malignant and unspecified (incl cycts and polyps)</p></td><td style="vertical-align:top"><p>Acute leukemia<sup>3</sup></p><p>Myelodysplastic syndrome</p><p>Secondary&nbsp;tumours</p><p>Bladder cancer</p><p>Tumour lysis syndrome</p></td><td style="vertical-align:top"><p>Rare</p><p>Rare</p><p>Rare</p><p>Rare</p><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>Myelosuppression <sup>4</sup><s> </s></p><p>Haemolytic uraemic syndrome&nbsp;</p><p>Disseminated intravascular coagulation (DIC ) Lymphopenia</p></td><td style="vertical-align:top"><p>Very common</p><p>Very common</p><p>Very rare</p><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>Immunosuppression</p><p>Anaphylactic/Anaphylactoid reaction</p><p>Hypersensitivity reaction</p></td><td style="vertical-align:top"><p>Very common</p><p>Very rare</p><p>Uncommon</p></td></tr><tr><td style="vertical-align:top"><p>Endocrine disorders</p></td><td style="vertical-align:top"><p>SIADH</p></td><td style="vertical-align:top"><p>Rare</p></td></tr><tr><td style="vertical-align:top"><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top"><p>Anorexia</p><p>Dehydration</p><p>Hyponatraemia</p><p>Fluid retention</p><p>Blood glucose changes (increase or decrease)</p></td><td style="vertical-align:top"><p>Uncommon</p><p>Rare</p><p>Very rare</p><p>Very rare</p><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Psychic disorders</p></td><td style="vertical-align:top"><p>Confusion</p></td><td style="vertical-align:top"><p>Very rare</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Dizziness</p><p>Convulsion</p><p>Neurotoxicity<sup>5</sup></p><p>Encephalopathy</p></td><td style="vertical-align:top"><p>Rare</p><p>Very rare</p><p>Unknown</p><p>Unknown</p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>Conjunctivitis</p><p>Eye Oedema</p><p>Visual impairment</p><p>Lacrimation increased</p></td><td style="vertical-align:top"><p>Very Rare</p><p>Very Rare</p><p>Rare</p><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Ear and labyrinth disorders</p></td><td style="vertical-align:top"><p>Deafness</p><p>Tinnitus</p></td><td style="vertical-align:top"><p>Not known</p><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>Ventricular fibrillation</p><p>Ventricular tachycardia</p><p>Cardiogenic shock</p><p>Pericardial effusion</p><p>Myocardial infarction</p><p>Cardiac failure</p><p>Cardiomyopathy</p><p>Myocarditis</p><p>Pericarditis</p><p>Electrocardiogram QT prolonged</p><p>Arrhythmias<sup>6</sup></p></td><td style="vertical-align:top"><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Flushing</p><p>Pulmonary embolism</p><p>Venous thrombosis</p><p>Vasculitis</p><p>Peripheral ischaemia</p></td><td style="vertical-align:top"><p>Uncommon</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>Pulmonary veno-occlusive disease</p><p>Acute respiratory distress syndrome (ARDS)</p><p>Interstitial Lung Diseases<sup>7</sup></p><p>Pulmonary hypertension</p><p>Pulmonary oedema</p><p>Bronchospasm</p><p>Dyspnea</p><p>Hypoxia</p><p>Cough</p><p>Nasal congestion</p><p>Rhinorrhea</p><p>Oropharyngeal pain</p></td><td style="vertical-align:top"><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Enterocolitis haemorrhagic</p><p>Acute pancreatitis</p><p>Mucosal ulceration</p><p>Stomatitis</p><p>Diarrhoea</p><p>Vomiting</p><p>Constipation</p><p>Nausea</p><p>Gastrointestinal Haemorrhage</p><p>Colitis</p><p>Enteritis</p><p>Cecitis</p><p>Abdominal pain</p><p>Parotid gland inflammation</p></td><td style="vertical-align:top"><p>Very rare</p><p>Very rare</p><p>Very rare</p><p>Very rare</p><p>Very rare</p><p>Very rare</p><p>Very rare</p><p>Very rare</p><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p></td></tr><tr><td style="vertical-align:top"><p>Hepatobiliary disorders</p></td><td style="vertical-align:top"><p>Hepatic function abnormal</p><p>Veno-occlusive disorder</p><p>Hepatitis</p><p>Cholestasis</p><p>Hepatotoxicity<sup>8</sup></p></td><td style="vertical-align:top"><p>Common</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>Alopecia</p><p>Rash</p><p>Dermatitis</p><p>Discoloration of the palms, fingernails, soles</p><p>Toxic epidermal necrolysis</p><p>Stevens Johnson syndrome</p><p>Erythema multiforme</p><p>Palmar-plantar erythrodysaesthesia</p><p>Radiation recall dermatitis</p><p>Erythema in irradiated area</p><p>Pruritus (including inflammatory itching)</p><p>Erythema</p><p>Urticaria</p><p>Blisters</p><p>Facial swelling</p><p>Hyperhidrosis</p></td><td style="vertical-align:top"><p>Very common</p><p>Rare</p><p>Rare</p><p>Rare</p><p>Very rare</p><p>Very rare</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p>Rhabdomyolysis</p><p>Scleroderma</p><p>Muscle spasms</p><p>Myalgia</p><p>Arthralgia</p></td><td style="vertical-align:top"><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Renal and urinary disorders</p></td><td style="vertical-align:top"><p>Cystitis</p><p>Microhematuria</p><p>Haemorrhagic cystitis</p><p>Macrohematuria</p><p>Suburethral bleeding</p><p>Oedema of the bladder wall</p><p>Interstitial inflammation, fibrosis, and sclerosis of bladder</p><p>Renal failure</p><p>Blood creatinine increased</p><p>Renal tubular necrosis</p><p>Renal tubular disorder</p><p>Nephropathy toxic</p><p>Hemorrhagic ureteritis</p><p>Cystitis ulcerative</p><p>Bladder contracture</p><p>Nephrogenic diabetes insipidus</p><p>Atypical urinary bladder epithelial cells</p><p>Blood urea nitrogen increased</p></td><td style="vertical-align:top"><p>Very common</p><p>Very common</p><p>Common</p><p>Common</p><p>Very rare</p><p>Very rare</p><p>Very rare</p><p>&nbsp;</p><p>Very rare</p><p>Very rare</p><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p></td></tr><tr><td style="vertical-align:top"><p>Pregnancy, puerperium and perinatal conditions</p></td><td style="vertical-align:top"><p>Premature labour</p></td><td style="vertical-align:top"><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Reproductive system and breast disorders</p></td><td style="vertical-align:top"><p>Impairment of spermatogenesis</p><p>Ovulation disorder</p><p>Amenorrhoea<sup>9</sup></p><p>Azoospermia<sup>9</sup></p><p>Oligospermia<sup>9</sup></p><p>Infertility</p><p>Ovarian Failure</p><p>Oligomenorrhoea,</p><p>Testicular atrophy</p><p>Blood oestrogen decreased</p><p>Blood gonadotrophin increased</p></td><td style="vertical-align:top"><p>Common</p><p>Uncommon</p><p>Rare</p><p>Rare</p><p>Rare</p><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p><p>Unknown</p></td></tr><tr><td style="vertical-align:top"><p>Congenital, familial and genetic disorders</p></td><td style="vertical-align:top"><p>Intra-uterine death</p><p>Fetal malformation</p><p>Fetal growth retardation</p><p>Fetal toxicity (including myelosuppression/gastroenteritis)</p></td><td style="vertical-align:top"><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>Fever</p><p>Asthenia</p><p>Mucosal inflammation</p><p>Chest pain</p><p>Headache</p><p>Injection/infusion site reactions<sup>10</sup>&nbsp;</p><p>Multiorgan failure</p><p>Oedema</p><p>Influenza-like illness</p><p>General physical deterioration</p></td><td style="vertical-align:top"><p>Very common</p><p>Common</p><p>Common</p><p>Rare</p><p>Very Rare</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p><p>Not known</p></td></tr><tr><td style="vertical-align:top"><p>Investigations</p></td><td style="vertical-align:top"><p>Blood lactate hydrogenase increased</p><p>C-reactive protein increased</p></td><td style="vertical-align:top"><p>Not known</p><p>Not known</p></td></tr></tbody></table><p>&nbsp;</p><p><sup>1</sup> including other bacterial, fungal, viral, protozoal, parasitic, reactivation of latent infections, including viral hepatitis, tuberculosis, JC virus with progressive multifocal leucoencephalopathy (including fatal outcomes), Pneumocystis jiroveci, herpes zoster, Strongyloides</p><p><sup>2</sup>&nbsp; including fatal outcomes</p><p><sup>3</sup> including acute myeloid leukemia, acute promyelocytic leukemia</p><p><sup>4</sup> manifested as Bone marrow failure, Pancytopenia, Neutropaenia, Agranulocytosis, Granulocytopenia,Thrombocytopaenia (complicated by bleeding), Leukopenia, Anaemia</p><p><sup>5</sup> manifested as reversible posterior leukoencephalopathy syndrome, myelopathy, peripheral neuropathy, polyneuropathy,neuralgia, dysesthesia, hypoesthesia, paresthesia, tremor, dysgeusia, hypogeusia,parosmia.</p><p><sup>6</sup> manifested as Atrial fibrillation,Supraventricular arrhythmia ,Ventricular arrhythmia, Bradycardia, Tachycardia,Palpitation</p><p><sup>7</sup> manifested by pulmonary fibrosis, obliterative bronchiolitis, organizing pneumonia, alveolitis allergic, pneumonitis</p><p><sup>8 </sup>Hepatic failure, Hepatic encephalopathy, Ascites, Hepatomegaly, Jaundice, Blood bilirubin increased, Hepatic enzymes increased (ASAT, ALAT, ALP, gamma-GT)</p><p><sup>9</sup> persistent</p><p><sup>10</sup> manifested by thrombosis, necrosis, phlebitis, inflammation, pain, swelling, erythema.</p><p><strong>&nbsp;</strong></p><p><strong>Reporting of suspected adverse reactions</strong></p><p>&nbsp;</p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system as per following contact details:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia:</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:564px"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Toll free phone: 8002490000</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: www.sfda.gov.sa/npc</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States:</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:564px"><tbody><tr><td><p>-&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Serious consequences of overdosage include manifestations of dose dependent toxicities such as myelosuppression, urotoxicity, cardiotoxicity (including cardiac failure), veno-occlusive hepatic disease, and stomatitis.&nbsp; See Section 4.4.</p><p>Patients who received an overdose should be closely monitored for the development of toxicities, and haematotoxicity in particular.</p><p>No specific antidote for cyclophosphamide is known.</p><p>Cyclophophamide and its metabolites are dialysable. Consider haemodialysis in cases of severe overdose presenting early, particularly in patients with renal impairment</p><p>Overdosage should be managed with supportive measures, including appropriate, state-of-the-art treatment for any concurrent infection, myelosuppression, or other toxicity, should it occur.</p><p>Cystitis prophylaxis with mesna may be helpful in preventing or limiting urotoxic effects with cyclophosphamide overdose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cyclophosphamide has been demonstrated to have a cytostatic effect in many tumour types.&nbsp; The active metabolites of cyclophosphamide are alkylating agents which transfer alkyl groups to DNA during the process of cell division, thus preventing normal synthesis of DNA.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cyclophosphamide is well absorbed following an oral dose with a mean half-life of 4-8 hours for both oral and parenteral administration.</p><p>&nbsp;</p><p>It is an inactive pro drug with alkylating metabolites produced by hepatic metabolism, reaching peak levels 4-6 hours after an i.v. injection.&nbsp; Hepatic enzymes may be induced.&nbsp; The parent compound binds poorly to plasma protein but the active metabolites are significantly protein-bound.&nbsp; The drug is widely distributed and crosses the blood-brain barrier, the placental barrier and is found in ascites.&nbsp; The metabolites are excreted renally.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no pre-clinical data of relevance to the prescriber which are additional to the information already stated in other sections of the Summary of Product Characteristics.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Benzyl alcohol increases the degradation rate of cyclophosphamide.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Unopened
36 months.

After reconstitution for intravenous administration
Chemical and physical in-use stability has been demonstrated (in aqueous, sodium chloride, and glucose solutions) for 48 hours at 2   8°C.

From a microbiological point of view, the product should be used immediately.  If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2   8°C, unless reconstitution has taken place in controlled and validated aseptic conditions.

After reconstitution in Aromatic Elixir USP for oral administration
At a concentration of 2 mg cyclophosphamide per ml in Aromatic Elixir USP, chemical and physical stability has been demonstrated for 14 days at 2   8°C.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 25&deg;C.</p><p>&nbsp;</p><p>Store in original container.</p><p>&nbsp;</p><p>After reconstitution (for either intravenous or oral administration), store at 2 ‑ 8&deg;C and protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>50 ml type I or type III glass vials with butyl rubber closures and plastic and aluminium caps.</p><p>&nbsp;</p><p>Pack size : 1 vial.</p><p>&nbsp;</p><p>Vials are packed with or without a protective plastic overwrap. Protective plastic overwrap does not come into contact with the medicinal product and provides additional</p><p>transport protection, which increases the safety for the medical and pharmaceutical</p><p>personnel.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>For intravenous administration</em></p><p>Prior to administration the contents of a vial should be dissolved in 25 ml physiological saline (0.9% w/v sodium chloride) by introducing the saline into the vial and shaking vigorously until the powder is completely dissolved.&nbsp; Reconstitution results in a clear solution with a pH of between 4 and 6.</p><p>&nbsp;</p><p>Cyclophosphamide Injection is compatible with the following infusion solutions: sodium chloride solution, glucose solution, sodium chloride and glucose solution, sodium chloride and potassium chloride solution, and potassium chloride and glucose solution.</p><p>&nbsp;</p><p><em>For oral administration</em></p><p>Cyclophosphamide Injection may be dissolved in Aromatic Elixir USP.</p><p>&nbsp;</p><p><em>General instructions</em></p><p>If vials are stored above the recommended temperature this can cause degradation of the active ingredient, identifiable by a yellow melted appearance to the vial contents.&nbsp; Vials containing melted material should not be used.</p><p>&nbsp;</p><p>Cyclophosphamide is a cytotoxic agent.<strong> </strong>The handling and preparation of cyclophosphamide should always be in accordance with current guidelines on safe handling of cytotoxic agents.&nbsp; The material should not be handled by women who are pregnant or who are breast-feeding.</p><p><strong>&nbsp;</strong></p><p>Adequate care and precautions should be taken in the disposal of empty vials and items (syringes, needles, etc) used in reconstitution and administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Baxter Oncology GmbH
Kantstraße 2
33790 Halle/Westfalen
Germany
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                7 June 2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>